рофессиональная
библиотека
Актуальное с 2020 года
Актуальные статьи с 2020 года
Источники на русском языке
Иностранные источники
Клинические рекомендации «Интраокулярная ретинобластома» (ID КР71/1). Одобрены Научно-практическим Советом Минздрава РФ. Год утверждения: 2020 год.
http://cr.rosminzdrav.ru/recomend/71_1


А

Алексеева Е.А., Бабенко О.В., Козлова В.М., Ушакова Т.Л., Казубская Т.П., Танас А.С., Карандашева К.И., Стрельников В.В., Залетаев Д.В. Преимущества высокопроизводительного параллельного секвенирования в выявлении соматического мозаицизма при спорадической ретинобластоме. Медицинская генетика. 2020. Т. 19. № 6 (215). С. 6-7.
https://www.elibrary.ru/item.asp?id=44127160

Б

Бабкина А.В., Кулыгин Б.Б. Современные представления о ретинобластоме у детей. Научный альманах. 2020, № 4-1 (66).
https://www.elibrary.ru/item.asp?id=43025221

Базарбаева А.А., Кәрімова М., Таубалдиева З.Е. Анализ результатов лечения ретинобластомы у детей. Педиатрия и детская хирургия. 2020. № 1 (99). С. 13-17.
https://www.elibrary.ru/download/elibrary_44063343_42129189.pdf

Белоусова Е.И., Матинян Н.В., Мартынов Л.А., Ушакова Т.Л., Гьокова Е.В. Эффективность и безопасность ретробульбарной блокады 0,5% ропивакаином при проведении операции энуклеации глазного яблока у детей. Детская хирургия. 2020. Т. 24. № S1. С. 25.
http://www.fesmu.ru/elib/Article.aspx?id=391153

Белоусова Е.И., Матинян Н.В., Ушакова Т.Л., Поляков В.Г. Ретробульбарная блокада при энуклеации глазного яблока у детей с ретинобластомой. Офтальмохирургия. 2021. № 2. С. 52-57.
DOI 10.25276/0235-4160-2021-2-52-57

Боброва Н.Ф., Сорочинская Т.А., Молчанюк Н.И., Братишко А.Ю.
Ультраструктурные изменения сетчатки кролика при однократном интравитреальном введении различных доз мелфалана.
Офтальмологический журнал. 2020. № 4 (495). С. 50-55.
https://www.elibrary.ru/item.asp?id=44155830

В

Володин Д.П., Котельникова А.В., Котова Е.С., Яровой А.А.
Дифференциальная диагностика ретинобластомы и симулирующих состояний (псевдоретинобластом)
Медицинский вестник Башкортостана. 2020. Т. 15. № 4 (88). С. 44-47.
DOI: https://doi.org/10.25276/2307-6658-2020-4-51-58
https://eyepress.ru/article.aspx?44174

Г

Гараев Т.И., Матненко Т.Ю., Кучкова Ю.Е. Заболеваемость ретинобластомой в Омской области по данным БУЗОО «КОБ им. В. П. Выходцева». В сборнике: Неделя молодежной науки - 2021. Материалы Всероссийского научного форума с международным участием, посвященного медицинским работникам, оказывающим помощь в борьбе с коронавирусной инфекцией. Тюмень, 2021. С. 257.
https://www.elibrary.ru/item.asp?id=45682805

И

Иванова С.В., Кулева С.А., Садовникова Н.Н., Комиссаров М.И., Чистякова М.Н., Хохлова А.В., Щеголева Н.А. Принципы терапии интраокулярной ретинобластомы. РМЖ. Клиническая офтальмология. 2020. Т. 20. № 4. С. 197-203.
doi: 10.32364/2311-7729-2020-20-4-197-203
https://www.elibrary.ru/item.asp?id=44326007

Иванова С.В., Кулева С.А., Садовникова Н.Н., Комиссаров М.И., Чистякова М.Н., Хохлова А.В., Щеголева Н.А. Ретинобластома. Часть 1. Клинико-диагностические аспекты. РМЖ. Клиническая офтальмология. 2020. Т. 20. № 3. С. 159-164.
https://www.rmj.ru/articles/oftalmologiya/Retinoblastoma_Chasty_1_Kliniko-diagnosticheskie_aspekty/
К

Котельникова А.В., Котова Е.С., Володин Д.П., Ушакова Т.Л., Яровой А.А.
Первичное эндопротезирование глазницы при энуклеации по поводу ретинобластомы. Российская детская офтальмология. 2021. № 1. С. 44-49.
doi: 10.25276/2307-6658-2021-l-44-49
https://www.elibrary.ru/item.asp?id=44888607

Котова Е.С., Яровой А.А., Бузуртанов М.Б. Эффективность локального лечения ретинобластомы на крайней периферии глазного дна.
Современные технологии в офтальмологии. 2020. № 3 (34). С. 110-111.
doi: 10.25276/2312-4911-2020-3-110-111
https://eyepress.ru/article.aspx?43403

Котова Е.С., Яровой А.А., Володин Д.П., Котельникова А.В. Брахитерапия ретинобластомы (обзор литературы). Российский журнал детской гематологии и онкологии. 2021. Т. 8. № 1. С. 50-56.
doi: 10.21682/2311-1267-2021-8-1-50-56
https://www.elibrary.ru/item.asp?id=45081117

М

Макаревич О.О. Интравитреальные инъекции в лечении ретинобластомы. Вестник Витебского государственного медицинского университета. Том 19, номер 3.
DOI: 10.22263/2312-4156.2020.3.7.
https://www.elibrary.ru/item.asp?id=42992359

Макаревич О.О. Ретинобластома: клинические проявления и особенности диагностики у детей. Педиатрия. Восточная Европа. 2020. Т. 8. № 2.
doi: 10.34883/PI.2020.8.2.010
https://elibrary.ru/item.asp?id=43154294

Макаревич О.О. Транспупиллярная термотерапия в лечении ретинобластомы. Евразийский онкологический журнал.
DOI: 10.34883/PI.2020.8.1.019
https://elibrary.ru/item.asp?id=42705485

Н

Науменко Л.В., Малиновский Г.Ф., Красный С.А., Жиляева Е.П., Бараш А.Н., Жерко И.Ю. Использование аллотрансплантата из подкожно-жировой клетчатки с апоневрозом подошвы для формирования опорно-двигательной культи при энуклеации. Новости хирургии. 2021. Т. 29. № 2. С. 191-197.
doi: 10.18484/2305-0047.2021.2.191
https://www.elibrary.ru/item.asp?id=45746866

П

Погребняков И.В., Ушакова Т.Л., Трофимов И.А., Горовцова О.В., Матинян Н.В., Виршке Э.Р., Поляков В.Г., Долгушин Б.И. Осложнения селективной интраартериальной химиотерапии у детей с интраокулярной ретинобластомой // Онкологический журнал: лучевая диагностика, лучевая терапия. 2021. Т.4. № 2. С. 69-83.
DOI 10.37174/2587-7593-2021-4-2-69-83.
https://www.elibrary.ru/item.asp?id=46181348

Р

Ретинобластома. Covid-19. Российский журнал детской гематологии и онкологии (РЖДГиО). Специальный выпуск, 2020.
https://cloud.mail.ru/public/5zHE/3wR92vLQh

С

Саакян С.В., Иванова О.А., Тадевосян С.С., Цыганков А.Ю., Ольхова Л.В., Ушакова Т.Л., Поляков В.Г. Выживаемость больных ретинобластомой по данным когортного исследования двух центров РФ. Российский офтальмологический журнал. 2021; 14(1):47-55.
https://doi.org/10.21516/2072-0076-2021-14-1-47-55

Саакян С.В., Иванова О.А., Тадевосян С.С., Цыганков А.Ю., Ольхова Л.В., Ушакова Т.Л., Поляков В.Г. Результаты пятилетней выживаемости при комбинированном лечении больных ретинобластомой. Российский общенациональный офтальмологический форум. 2020. Т. 2. С. 342-345.
https://www.elibrary.ru/item.asp?id=44450844

Саакян С.В., Мякошина Е.Б., Исмаилова Д.М. Токсическое влияние цитостатиков на изменения морфометрических параметров сетчатки и хориоидеи на фоне химиотерапии ретинобластомы.
Эффективная фармакотерапия. 2021. Т. 17. № 8. С. 12-15.
doi: 10.33978/2307-3586-2021-17-8-12-15
https://www.elibrary.ru/item.asp?id=45049320

Саакян С.В., Мякошина Е.Б., Поляков В.Г., Ушакова Т.Л., Исмаилова Д. М. Оптическая когерентная томография в доклинической диагностике изменений диска зрительного нерва после химиотерапии у детей с ретинобластомой. Российский офтальмологический журнал. №2. 2020.
DOI: 10.21516/2072-0076-2020-13-2-53-58
https://www.elibrary.ru/item.asp?id=42870509
https://roj.igb.ru/jour/article/view/431/294

Саакян С.В., Тадевосян С.С., А.Ю. Цыганков А.Ю. Анализ структуры заболеваемости ретинобластомой у детей. Российская педиатрическая офтальмология. 2020. Т.15, №4. С.5-10.
DOI: https://doi.org/10.17816/rpo2020-15-4-5-10.
https://www.elibrary.ru/item.asp?id=45615985

Саакян С.В., Тадевосян С.С., Цыганков А.Ю., Иванова О.А. Вторые опухоли у больных ретинобластомой в отдаленном периоде наблюдения (серия клинических случаев). Head and Neck/Голова и шея. Российское издание. Журнал Общероссийской общественной организации Федерация специалистов по лечению заболеваний головы и шеи. 2021. Т. 9. № 1. С. 83-90.
DOI: 10.25792/HN.2021.9.1.83-90
https://www.elibrary.ru/item.asp?id=44945729

Саакян С.В., Цыганков А.Ю., Тадевосян С.С., Макарова А.А., Коголева Л.В., Тацков Р.А. Аметропии у детей с ретинобластомой. Офтальмология. 2020;17(1):76-80.
https://doi.org/10.18008/1816-5095-2020-1-76-80

Саакян С.В., Цыганков А.Ю., Хорошилова-Маслова И.П., Моисеева Н.И., Карамышева А.Ф., Жильцова М.Г., Амирян А.Г., Тадевосян С.С. Разработка модели внутриглазной ретинобластомы invivo // Бюллетень экспериментальной биологии и медицины. 2020, Т. 169, № 3, март.
https://www.elibrary.ru/item.asp?id=42518484

Саакян С.В., Хорошилова-Маслова И.П., Тадевосян С.С., Цыганков А.Ю., Захарова Г.П., Иванова О.А., Жаруа А.А. Клинико-морфологическое исследование ретинобластомы после локальной химиотерапии. Российский общенациональный офтальмологический форум. 2020. Т. 2. С. 346-350.
https://www.elibrary.ru/item.asp?id=44450845

Саакян С.В., Хорошилова-Маслова И.П., Тадевосян С.С., Цыганков А.Ю., Захарова Г.П., Иванова О.А., Жаруа А.А. Морфогенез ретинобластомы при локальном введении цитостатиков. Точка зрения. Восток - Запад. 2020. № 3.
doi: 10.25276/2410-1257-2020-3-68-70
https://elibrary.ru/item.asp?id=43076292
https://eyepress.ru/article.aspx?42537

Садовникова Н.Н., Чистякова М.Н., Кулева С.А., Иванова С.В., Баранова Н.А. Ретинобластом. В книге "Неонатальная офтальмология: Руководство для врачей" / Н. А. Баранова, В. В. Бржеский, О. В. Дискаленко [и др.]. Москва, 2021. 288 с.
DOI 10.33029/9704-6152-5-NOF-2021-1-288.
У

Умарова Б.З. Анализ патологических изменений и их роль в ранней диагностике ретинобластомы. Новый день в медицине. 2020. № 4 (32). С. 452-454.
https://www.elibrary.ru/item.asp?id=45759436

Умарова Б.З. Скрининг в ранней диагностике ретинобластомы. Экономика и социум. №6-2 (73). Узбекистан.
https://www.elibrary.ru/item.asp?id=44002068

Умарова Б.З., Икрамов А.Ф., Исламов З.С. Содержание МДА в слёзной жидкости у больных ретинобластомой. Современные технологии в офтальмологии. 2020. № 3 (34). С. 45-46.
doi: 10.25276/2312-4911-2020-3-45-46
https://www.elibrary.ru/item.asp?id=44346105

Умарова Б.З., Исламов З.С., Икрамов А.Ф. Содержание общего белка в слезной жидкости у больных ретинобластомой. Современные технологии в офтальмологии. 2020. № 3 (34). С. 44-45.
doi: 10.25276/2312-4911-2020-3-44-45
https://eyepress.ru/article.aspx?43338

Ушакова Т.Л., Волкова А.В., Горовцова О.В., Яровой А.А., Яровая В.А., Котова Е.С., Мaтинян Н.В., Цинцадзе А.А., Трофимов И.А., Погребняков И.В., Долгушин Б.И., Поляков В.Г. Роль трехкомпонентной селективной интраартериальной химиотерапии при неудачах стандартного органосохраняющего лечения детей с интраокулярной ретинобластомой. Российский журнал детской гематологии и онкологии, выпуск №4, 2020.
https://doi.org/10.21682/2311-1267-2020-7-4-15-34

Я

Яровой А.А., Голанов А.В., Ушакова Т.Л., Костюченко В.В., Яровая В.А., Котова Е.С., Поляков В.Г. Стереотаксическая радиохирургия «Гамма-нож» при интраокулярной ретинобластоме: результаты пяти лет применения. Офтальмохирургия. 2021. № 1. С. 46-56.
doi: 10.25276/0235-4160-2021-1-39-45
https://www.elibrary.ru/item.asp?id=45538352

Яровой А.А., Горшков И.М., Ушакова Т.Л., Яровая В.А., Котова Е.С., Котельникова А.В. Хирургическое лечение гемофтальма с одновременной ирригацией мелфалана у пациентов с ретинобластомой. Российская детская офтальмология. № 2.
doi: 10.25276/2307-6658-2020-2-20-25
https://elibrary.ru/item.asp?id=43044874
https://eyepress.ru/article.aspx?42554

Яровой А.А., Клеянкина С.С., Зубарева С.А., Ушакова Т.Л., Яровая В.А., Котельникова А.В., Котова Е.С. Ретробульбарная инфузионная терапия интраокулярных осложнений локального лечения ретинобластомы. Российская детская офтальмология. 2020. № 2.
doi: 10.25276/2307-6658-2020-2-26-30
https://elibrary.ru/item.asp?id=43044875
https://eyepress.ru/article.aspx?42555

Яровой А.А., Козлова В.М., Яровая В.А., Котельникова А.В., Астарханова Д.С. Клинические особенности и течение ретиноцитомы. Российская детская офтальмология. 2020. № 1. С. 24-28.
https://doi.org/10.25276/2307-6658-2020-1-24-28

Яровой А.А., Котова Е.С., Котельникова А.В., Яровая В.А.
Дифференциальная диагностика ретинита Коатса и ретинобластомы
Медицинский вестник Башкортостана. 2020. Т. 15. № 4 (88). С. 44-47.
https://www.elibrary.ru/download/elibrary_44521850...

Яровой А.А., Ушакова Т.Л., Голубева О.В., Левашов И.А., Михайлова С.Н., Яровая В.А., Поляков В.Г. Ретинобластома: история одного пациента
Российский журнал детской гематологии и онкологии. 2020. Т. 7. № 2.
doi: 10.21682/2311-1267-2020-7-2-134-9
https://elibrary.ru/item.asp?id=43089362

Яровой А.А., Ушакова Т.Л., Иванова Н.В., Горовцова О.В., Котельникова А.В., Яровая В.А., Поляков В.Г. Первичное эндопротезирование орбиты как способ косметической реабилитации детей с ретинобластомой. Современные технологии в офтальмологии. 2020. № 4 (35). С. 175-176.
DOI: https://doi.org/10.25276/2312-4911-2020-4-175-176
https://eyepress.ru/article.aspx?43809
A

Abdelbaki M.S., Abu-Arja M.H., Davidson T.B., Fangusaro J.R., Stanek J.R., Dunkel I.J., Dhall G, Gardner SL, Finlay JL. Pineoblastoma in children less than six years of age: The Head Start I, II, and III experience. // Pediatric Blood & Cancer. 2020 Mar 18.
DOI: 10.1002/pbc.28252
https://pubmed.ncbi.nlm.nih.gov/32187454/?from_term=retinoblastoma&from_sort=date&from_pos=2

Abramson D.H., Bian Y., Belinsky I., Francis J.H. An in-utero presentation of trilateral retinoblastoma. Ophthalmology. Retina. 2020 Dec 26:S2468-6530(20)30504-2.
doi: 10.1016/j.oret.2020.12.017.
https://pubmed.ncbi.nlm.nih.gov/33373716/

Abramson D.H., Gobin Y.P., Dunkel I.J., Francis J.H. Successful Treatment of Massive Choroidal Invasion in Retinoblastoma with Intraarterial Chemotherapy (Ophthalmic Artery Chemosurgery). Ophthalmology. Retina. 2020 Dec 28:S2468-6530(20)30505-4.
doi: 10.1016/j.oret.2020.12.018.
https://pubmed.ncbi.nlm.nih.gov/33383259/

Abramson D.H., Haque S., Francis J.H. Prelaminar and Postlaminar Invasion of Retinoblastoma. Ophthalmology. Retina. 2021 Apr;5(4):387.
doi: 10.1016/j.oret.2020.12.015.
https://pubmed.ncbi.nlm.nih.gov/33814046/

Abramson D.H., Haque S., Francis J.H. Unilateral Retinoblastoma Metastatic to the Skull and Both Orbits. Ophthalmology Retina. 2020 Oct;4
doi: 10.1016/j.oret.2020.04.019.
https://pubmed.ncbi.nlm.nih.gov/33019985/

Abruzzo T., Abraham K., Karani K.B., Geller J.I., Vadivelu S., Racadio J.M., Zhang B., Correa Z.M. Correlation of Technical and Adjunctive Factors with Quantitative Tumor Reduction in Children Undergoing Selective Ophthalmic Artery Infusion Chemotherapy for Retinoblastoma. AJNR. American journal of neuroradiology. 2020 Dec 24.
doi: 10.3174/ajnr.A6905.
https://pubmed.ncbi.nlm.nih.gov/33361377/

Abusayf M.M., Alkatan H.M., Elkhamary S., Almesfer S.A., Maktabi A.M.Y.
Histopathological assessment of optic nerve invasion guided by radiological findings in enucleated globes with retinoblastoma. BMC Ophthalmology. 2020 Sep 29.
doi: 10.1186/s12886-020-01654-z.
https://pubmed.ncbi.nlm.nih.gov/32993566/

de Aguirre Neto J.C., Antoneli C.B., Ribeiro K.B., Castilho M.S., Novaes P.E., Chojniak M.M., Arias V. Retinoblastoma in children older than 5 years of age
Pediatric blood & cancer. 2007 Mar;48(3):292-5.
doi: 10.1002/pbc.20931.
https://pubmed.ncbi.nlm.nih.gov/16847922/

Akdemir Aktaş H., Ergun K.M., Tatar İ., Arat A., Hayran K.M.
Evaluation of the anastomoses between the ophthalmic artery and the middle meningeal artery by superselective angiography. Surgical and radiologic anatomy : SRA. 2020 Aug 16.
doi: 10.1007/s00276-020-02546-z.
https://pubmed.ncbi.nlm.nih.gov/32803306/

Alghofaili R. S., Almesfer S. A. Bilateral Retinoblastoma Presenting in an in vitro Fertilization Infant with Retinopathy of Prematurity. Case reports in ophthalmology, 12(1), 306–310. 2021 Apr 30;12(1):306-310.
doi: 10.1159/000513181
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138227/

Alkatan H.M., AlQahtani F.S., Maktabi A.M. Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th edition of the American Joint Committee on Cancer (AJCC). International Ophthalmology. 2020 Mar 19.
doi: 10.1007/s10792-020-01342-3.
https://pubmed.ncbi.nlm.nih.gov/32193778/?from_term=retinoblastoma&from_sort=pubdate&from_size=50&from_pos=34

Alkatan H.M., Al-Dahmash S.A., Almesfer S.A., AlQahtani F.S., Maktabi A.M.Y.
High-risk features in primary versus secondary enucleated globes with advanced retinoblastoma: a retrospective histopathological study. International ophthalmology. 2020 Jul 6.
doi: 10.1007/s10792-020-01472-8
https://pubmed.ncbi.nlm.nih.gov/32632618/

Al Saiegh F., Chalouhi N., Sweid A., Mazza J., Mouchtouris N., Khanna O., Tjoumakaris S., Gooch R, Shields CL, Rosenwasser R, Jabbour P. Intra-arterial chemotherapy for retinoblastoma via the transradial route: Technique, feasibility, and case series. Clinical Neurology and Neurosurgery. 2020 Apr 6
DOI: 10.1016/j.clineuro.2020.105824
https://pubmed.ncbi.nlm.nih.gov/32283473/?from_term=retinoblastoma&from_sort=date&from_pos=1

Alvarez-Suarez D.E., Tovar H., Hernández-Lemus E., Orjuela M., Sadowinski-Pine S., Cabrera-Muñoz L., Camacho J., Favari L., Hernández-Angeles A., Ponce-Castañeda M.V. Discovery of a transcriptomic core of genes shared in 8 primary retinoblastoma with a novel detection score analysis. J Cancer Res Clin Oncol. 2020 May 30.
doi: 10.1007/s00432-020-03266-y.
Online ahead of print. PMID: 32474753

Amin S., AlJboor M., Toro M.D., Rejdak R., Nowomiejska K., Nazzal R., Mohammad M., Al-Hussaini M., Khzouz J., Banat S., AlJabari R., Jaradat I., Mehyar M., Sultan I., AlNawaiseh I., Yousef Y.A.
Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma. Clinical ophthalmology. 2021 Jan 7;15:65-72.
doi: 10.2147/OPTH.S282741.
https://pubmed.ncbi.nlm.nih.gov/33447011/

Ancona-Lezama D., Dalvin L.A., Shields C.L. Modern treatment of retinoblastoma: A 2020 review. Indian journal of ophthalmology. 2020 Nov;68(11):2356-2365.
doi: 10.4103/ijo.IJO_721_20.
https://pubmed.ncbi.nlm.nih.gov/33120616/

Ancona-Lezama D., Garza-Garza L.A., Ruiz-Lozano R.E., Shields C.L., Villagomez-Valdez L.G., De-Leija-Portilla J.O. Diffuse infiltrative retinoblastoma with retinal detachment in "cinnamon-roll" configuration: a case report. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus / American Association for Pediatric Ophthalmology and Strabismus. 2020 Dec 18:S1091-8531(20)30315-3.
doi: 10.1016/j.jaapos.2020.10.004.
https://pubmed.ncbi.nlm.nih.gov/33348043/

Arshad R., Barani M., Rahdar A., Sargazi S., Cucchiarini M., Pandey S., Kang M. Multi-Functionalized Nanomaterials and Nanoparticles for Diagnosis and Treatment of Retinoblastoma. Biosensors. 2021 Mar 26;11(4):97.
doi: 10.3390/bios11040097.
https://pubmed.ncbi.nlm.nih.gov/33810621/

Arslan-Carlon V., Walline M.C., Seier K., Tan K.S., Abramson D.H. Hemodynamic Changes Associated with Mydriatic Eye Drop Administration in Anesthetized Pediatric Patients. Ocular oncology and pathology. 2020 May, 6.
doi: 10.1159/000500593.
https://pubmed.ncbi.nlm.nih.gov/32509766/

Aschero R., Francis J.H., Ganiewich D., Gomez-Gonzalez S., Sampor C., Zugbi S., Ottaviani D., Lemelle L., Mena M., Winter U., Correa Llano G., Lamas G., Lubieniecki F., Szijan I., Mora J., Podhajcer O., Doz F., Radvanyi F., Abramson D.H., Llera A.S., Schaiquevich P.S., Lavarino C., Chantada G.L. Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma.
Cancers (Basel). 2021 Feb 8;13(4):673.
doi: 10.3390/cancers13040673.
https://pubmed.ncbi.nlm.nih.gov/33567541/

Aubry A., Pearson J.D., Huang K., Livne-Bar I., Ahmad M., Jagadeesan M., Khetan V., Ketela T., Brown K.R., Yu T., Lu .S, Wrana J.L., Moffat J., Bremner R. Functional genomics identifies new synergistic therapies for retinoblastoma. ONCOGENE. 2020 Jun 22.
doi: 10.1038/s41388-020-1372-7
https://pubmed.ncbi.nlm.nih.gov/32572160/

Aubry A., Yu T., Bremner R. Preclinical studies reveal MLN4924 is a promising new retinoblastoma therapy. Cell Death Discov. 2020 Jan 20;6:2.
DOI: 10.1038/s41420-020-0237-8.
https://www.nature.com/articles/s41420-020-0237-8

B

Bakker M.A., Toom D.T., Damen T.H.C., Sleddens HFBM, Meijssen I.C., Deloose S., Kliffen M., Dinjens WNM. Anisometric Cell and Dysplastic Lipomas in a Retinoblastoma Patient. International journal of surgical pathology. 2020 May 4.
DOI: 10.1177/1066896920917220
https://pubmed.ncbi.nlm.nih.gov/32362169/?from_term=retinoblastoma&from_sort=date&from_page=5&from_pos=10

Balaji S., Santhi R., Kim U., Muthukkaruppan V., Priya C.G., Vanniarajan A. Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma. Current cancer drug targets. 2020 May 4
DOI: 10.2174/1568009620666200504112711
https://pubmed.ncbi.nlm.nih.gov/32364077/?from_term=retinoblastoma&from_sort=date&from_page=5&from_pos=9

Bao X.Y., Sun M., Peng T.T., Han D.M. TRIB3 promotes proliferation, migration, and invasion of retinoblastoma cells by activating the AKT/mTOR signaling pathway. Cancer biomarkers : section A of Disease markers. 2021 Apr 21.
doi: 10.3233/CBM-200050.
https://pubmed.ncbi.nlm.nih.gov/33896816/

Bas Z., Dalvin L.A., Tadepalli S., Rao R., Shah A., Leahey A.M., Shields C.L. Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 Patients. Asia-Pacific journal of ophthalmology. 2021 Jan 19.
doi: 10.1097/APO.0000000000000360.
https://pubmed.ncbi.nlm.nih.gov/33481399/

Batu Oto B., Sarıcı A.M., Kızılkılıç O. Superselective intra-arterial chemotherapy treatment for retinoblastoma: clinical experience from a tertiary referral centre. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2020 Jun 8.
doi: 10.1016/j.jcjo.2020.04.009
https://pubmed.ncbi.nlm.nih.gov/32527493/

Berry J.L., Munier F.L., Gallie B.L., Polski A., Shah S., Shields C.L., Gombos D.S., Ruchalski K., Stathopoulos C., Shah R., Jubran R., Kim J.W., Mruthyunjaya P., Marr B.P., Wilson M.W., Brennan R.C., Chantada G.L., Chintagumpala M.M., Murphree A.L. Response criteria for intraocular retinoblastoma: RB-RECIST. Pediatric blood & cancer. 2021 Feb 23:e28964.
doi: 10.1002/pbc.28964.
https://pubmed.ncbi.nlm.nih.gov/33624399/

Berry J.L., Munier F.L., Gallie B.L., Polski A., Shah S., Shields C.L., Gombos D.S., Ruchalski K., Stathopoulos C., Shah R., Jubran R., Kim J.W., Mruthyunjaya P., Marr B.P., Wilson M.W., Brennan R.C., Chantada G.L., Chintagumpala M.M., Murphree A.L. Response criteria for intraocular retinoblastoma: RB-RECIST. Pediatric blood & cancer. 2021 May;68(5):e28964.
doi: 10.1002/pbc.28964.
https://pubmed.ncbi.nlm.nih.gov/33624399/

Bhaduri A., Das S., Bansal S., Shree N. Smartphone Wide-Field Fundus Photography in Retinoblastoma With a Nasal Endoscope. Indian journal of ophthalmology. 2020 Jul.
doi: 10.4103/ijo.IJO_1666_19.
https://pubmed.ncbi.nlm.nih.gov/32587146/
http://www.ijo.in/temp/IndianJOphthalmol6871255-3887954_104759.pdf

Biewald E., Kiefer T., Geismar D., Schlüter S., Manthey A., Westekemper H., Wulff J., Timmermann B., Ketteler P., Schönberger S., Metz K.A., Ting S., Göricke S., Bechrakis N.E., Bornfeld N. Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Cancers. 2021 Apr 13;13(8):1862.
doi: 10.3390/cancers13081862.
https://pubmed.ncbi.nlm.nih.gov/33924716/

Bogan C.M., Kaczmarek J.V., Pierce J.M., Chen S.C., Boyd K.L., Calcutt M.W., Bridges T.M., Lindsley C.W., Nadelmann J.B., Liao A., Hsieh T., Abramson D.H., Francis J.H., Friedman D.L., Richmond A., Daniels A.B. Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study. The British journal of ophthalmology. 2021 May 10:bjophthalmol-2020-318529.
doi: 10.1136/bjophthalmol-2020-318529.
https://pubmed.ncbi.nlm.nih.gov/33972235/

Bogan C.M., Pierce J.M., Doss S.D., Tao Y.K., Chen S.C., Boyd K.L., Liao A., Hsieh T., Abramson D.H., Francis J.H., Friedman D.L., Richmond A., Daniels A.B. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients. Experimental eye research. 2021 Jan 11;204:108439.
doi: 10.1016/j.exer.2021.108439.
https://pubmed.ncbi.nlm.nih.gov/33444583/

Borah N.A., Sradhanjali S., Barik M.R., Jha A., Tripathy D., Kaliki S., Rath S., Raghav S.K., Patnaik S., Mittal R., Reddy M.M. Aurora Kinase B Expression, Its Regulation and Therapeutic Targeting in Human Retinoblastoma. Investigative ophthalmology & visual science. 2021 Mar 1;62(3):16.
doi: 10.1167/iovs.62.3.16.
https://pubmed.ncbi.nlm.nih.gov/33704359/

Bornfeld N., Lohmann D., Bechrakis N.E., Biewald E. [Retinoblastoma]. // Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. Ophthalmologe. 2020 Mar 23.
DOI: 10.1007/s00347-020-01081-x.
https://pubmed.ncbi.nlm.nih.gov/32206913/?from_term=retinoblastoma&from_sort=date&from_pos=3

Bossacoma F., Cuadrado-Vilanova M., Vinent J., Correa M.G., Gavrus D., Castillo-Ecija H., Catala-Mora J., Mora J., Schaiquevich P., Chantada G.L., Carcaboso AM. Optimizing the storage of chemotherapeutics for ophthalmic oncology: stability of topotecan solution for intravitreal injection. Ophthalmic genetics. 2020 Jun 3.
doi: 10.1080/13816810.2020.1776336
https://pubmed.ncbi.nlm.nih.gov/32490703/

Bourkiza R., Cumberland P., Fabian I.D., Abeysekera H., Parulekar M., Sagoo M.S., Rahi J., Reddy M.A. Role of ethnicity and socioeconomic status (SES) in the presentation of retinoblastoma: findings from the UK. BMJ Open Ophthalmology. 2020 May 15.
DOI: 10.1136/bmjophth-2019-000415
https://pubmed.ncbi.nlm.nih.gov/32432168/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=2

Bowman R.J.C., Foster A., Stacey A., Keren-Froim N., Bascaran C., Kivelä T.T., Munier F., Fabian I.D. International travel to obtain medical treatment for primary retinoblastoma: A global cohort study. International journal of cancer. 2020 Oct 18.
doi: 10.1002/ijc.33350.
https://pubmed.ncbi.nlm.nih.gov/33070355/

Bowman R.J.C., Foster A., Stacey A., Keren-Froim N., Bascaran C., Kivelä T.T., Munier F., Fabian I.D. International travel to obtain medical treatment for primary retinoblastoma: A global cohort study. International journal of cancer. 2021 Apr 15;148(8):1858-1866.
doi: 10.1002/ijc.33350.
https://pubmed.ncbi.nlm.nih.gov/33070355/

Burges M., Qaddoumi I., Brennan R.C., Krull L., Sahr N., Rodriguez-Galindo C., Jeha S., Wilson M.W. Assessment of Retinoblastoma Capacity in the Middle East, North Africa, and West Asia Region. JCO Global Oncology. 2020 Oct; 6.
doi: 10.1200/GO.20.00321.
https://pubmed.ncbi.nlm.nih.gov/33064626/

C

Calotti M., Yaghy A., Shields C.L. Painful Glaucoma and Pseudohypopyon in a Child with Retinoblastoma. Ophthalmology. Glaucoma. 2020 Nov-Dec;3(6):480.
doi: 10.1016/j.ogla.2020.07.004.
https://www.ophthalmologyglaucoma.org/article/S2589-4196(20)30186-1/pdf

Cancela M.B., Zugbi S., Winter U., Martinez A.L., Sampor C., Sgroi M., Francis J.H., Garippa R., Abramson D.H., Chantada G., Schaiquevich P. A decision process for drug discovery in retinoblastoma. Investigational new drugs. 2020 Nov 16.
doi: 10.1007/s10637-020-01030-0.
https://pubmed.ncbi.nlm.nih.gov/33200242/

Cao M., Wang S., Zou J., Wang W. Bioinformatics analyses of retinoblastoma reveal the retinoblastoma progression subtypes. PeerJ. 2020 May 21.
doi: 10.7717/peerj.8873
https://pubmed.ncbi.nlm.nih.gov/32509443/

Castro-Magdonel B.E., Orjuela M., Alvarez-Suarez D.E., Camacho J., Cabrera-Muñoz L., Sadowinski-Pine S., Medina-Sanson A., Lara-Molina C., García-Vega D., Vázquez Y., Durán-Figueroa N., Orozco-Romero M.J., Hernández-Ángeles A., Ponce-Castañeda M.V. Circulating miRNome Detection Analysis Reveals 537 miRNAS in Plasma, 625 in Extracellular Vesicles and a Discriminant Plasma Signature of 19 miRNAs in Children With Retinoblastoma From Which 14 Are Also Detected in Corresponding Primary Tumors. PLoS One. 2020 Apr 14.
DOI: 10.1371/journal.pone.0231394
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156076/

Chai P., Luo Y., Yu J., Li Y., Yang J., Zhuang A., Fan J., Han M., Jia R. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients. Experimental eye research. 2021 Apr;205:108456.
doi: 10.1016/j.exer.2021.108456.
https://pubmed.ncbi.nlm.nih.gov/33493472/

Chakumatha E., Weijers J., Banda K., Bailey S., Molyneux E., Chagaluka G., Israels T. Outcome at the end of treatment of patients with common and curable childhood cancer types in Blantyre, Malawi. Pediatric blood & cancer. 2020 May 11.
DOI: 10.1002/pbc.28322
https://pubmed.ncbi.nlm.nih.gov/32391955/?from_term=retinoblastoma&from_sort=date&from_page=4&from_pos=6

Chawla B., Bhaskaran K., Dada T., Bajaj M.S., Kashyap S., Shende D. Evaluation of the role of ultrasound biomicroscopy in advanced retinoblastoma: A prospective study on Asian Indian children. Ophthalmic Genetics. 2020 Mar 16.
DOI: 10.1080/13816810.2020.1737946
https://pubmed.ncbi.nlm.nih.gov/32176559/?from_term=retinoblastoma&from_sort=pubdate&from_size=50&from_pos=40

Chen N.N., Chao D.L., Li X.G. Circular RNA has_circ_0000527 participates in proliferation, invasion and migration of retinoblastoma cells via miR-646/BCL-2 axis. Cell Biochemistry & Function. 2020 Apr 7.
DOI: 10.1002/cbf.3535
https://pubmed.ncbi.nlm.nih.gov/32266733/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=3

Chen P.Y., Kao L.Y., Chao A.N., Wu W.C., Sun M.H., Su W.W., Liu C.H. Retinoblastoma in Taiwan: survival and clinical characteristics. Japanese journal of ophthalmology. 2021 May 4.
doi: 10.1007/s10384-021-00836-6.
https://pubmed.ncbi.nlm.nih.gov/33948759/

Chen Q., Zhang B., Dong Y., Mo X., Zhang L., Xia J., Zhang J., Zhang S. Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma. // Cancer Chemotherapy and Pharmacology. 2020 Mar 2.
DOI: 10.1007/s00280-020-04036-w
https://www.ncbi.nlm.nih.gov/pubmed/32123960

Chen S., Chen X., Qiu J., Chen P., Han X., Wu Y., Zhuang J., Yang M., Wu C., Wu N., Yang Y., Ge J., Yu K., Zhuang J. Exosomes derived from retinoblastoma cells enhance tumour deterioration by infiltrating the microenvironment. Oncology reports. 2021 Jan;45(1):278-290.
doi: 10.3892/or.2020.7858.
https://pubmed.ncbi.nlm.nih.gov/33416154/

Chen W.J., Sun C.X., Li W. Mechanism of FGF7 Gene Silencing in Regulating Viability, Apoptosis, Invasion of Retinoblastoma Cell Line HXO-Rb44 and Angiogenesis. European review for medical and pharmacological sciences. 2020 Apr 24
DOI: 10.26355/eurrev_202004_20814
https://pubmed.ncbi.nlm.nih.gov/32329827/?from_term=retinoblastoma&from_sort=date&from_pos=7

Che S., Wu S., Yu P. Lupeol induces autophagy and apoptosis with reduced cancer stem-like properties in retinoblastoma via phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin inhibition. J Pharm The Journal of pharmacy and pharmacology. 2021 Apr 9:rgab060.
doi: 10.1093/jpp/rgab060.
https://pubmed.ncbi.nlm.nih.gov/33836050/

Choi W.J., Jo D.H., Kang H.J., Shin H.Y., Yu Y.S., Kim J.H. Development of New Solitary Retinoblastoma Tumors during and after Chemotherapy. Korean journal of ophthalmology : KJO. 2021 Feb;35(1):73-79.
doi: 10.3341/kjo.2020.0115.
https://pubmed.ncbi.nlm.nih.gov/33596616/

Cho S.J., Kim J.H., Baik S.H., Sunwoo L., Bae Y.J., Choi B.S. Diagnostic performance of MRI of post-laminar optic nerve invasion detection in retinoblastoma: A systematic review and meta-analysis. Neuroradiology. 2020 Aug 31
doi: 10.1007/s00234-020-02538-1.
https://pubmed.ncbi.nlm.nih.gov/32865636/

Cho S.J., Kim J.H., Baik S.H., Sunwoo L., Bae Y.J., Choi B.S. Diagnostic performance of MRI of post-laminar optic nerve invasion detection in retinoblastoma: A systematic review and meta-analysis. Neuroradiology. 2021 Apr;63(4):499-509.
doi: 10.1007/s00234-020-02538-1.
https://pubmed.ncbi.nlm.nih.gov/32865636/

Chou J.F., Ford J.S., Kleinerman R.A., Abramson D.H., Francis J.H., Sklar C.A., Oeffinger K.C., Robison L.L., Dunkel I.J., Friedman D.N. General cancer screening practices among adult survivors of retinoblastoma: Results from the Retinoblastoma Survivor Study. Pediatric blood & cancer. 2021 Jan 26:e28873.
doi: 10.1002/pbc.28873.
https://pubmed.ncbi.nlm.nih.gov/33501778/

Chou J.F., Ford J.S., Kleinerman R.A., Abramson D.H., Francis J.H., Sklar C.A., Oeffinger K.C., Robison L.L., Dunkel I.J., Friedman D.N. General cancer screening practices among adult survivors of retinoblastoma: Results from the Retinoblastoma Survivor Study. Pediatric blood & cancer. 2021 Apr;68(4):e28873.
doi: 10.1002/pbc.28873.
https://pubmed.ncbi.nlm.nih.gov/33501778/

Cho Y.J., Jung D.E., Oh Y., Nam K., Lee H.C., Jeon Y., Cho Y.D., Kim T.K. Heart rate variability and oxygen reserve index during cardiorespiratory events in patients undergoing ophthalmic arterial chemotherapy: a prospective observational study. Journal of clinical monitoring and computing. 2021 Mar 18.
doi: 10.1007/s10877-021-00687-z.
https://pubmed.ncbi.nlm.nih.gov/33733371/

Clarissa A., Sutandi N., Fath A.A. Stem-Cell Therapy Following High-Dose Chemotherapy in Advanced Retinoblastoma: A Systematic Review. Asia-Pacific journal of ophthalmology. 2021 Jan 19.
doi: 10.1097/APO.0000000000000372.
https://pubmed.ncbi.nlm.nih.gov/33481395/

Cobbs L.V., Francis J.H., Dunkel I.J., Gobin Y.P., Brodie S.E., Abramson D.H. Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions. Pediatric blood & cancer. 2020 Dec 23:e28845.
doi: 10.1002/pbc.28845.
https://pubmed.ncbi.nlm.nih.gov/33355996/\

Cobbs L.V., Francis J.H., Dunkel I.J., Gobin Y.P., Brodie S.E., Abramson D.H. Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions. Pediatric blood & cancer. 2021 May;68(5):e28845.
doi: 10.1002/pbc.28845.
https://pubmed.ncbi.nlm.nih.gov/33355996/

Collin J., Queen R., Zerti D., Steel D.H., Bowen C., Parulekar M., Lako M. Dissecting the Transcriptional and Chromatin Accessibility Heterogeneity of Proliferating Cone Precursors in Human Retinoblastoma Tumors by Single Cell Sequencing-Opening Pathways to New Therapeutic Strategies?
Investigative ophthalmology & visual science. 2021 May 3;62(6):18.
doi: 10.1167/iovs.62.6.18.
https://pubmed.ncbi.nlm.nih.gov/34003213/

Conroy L.R., Dougherty S., Kruer T., Metcalf S., Lorkiewicz P., He L., Yin X., Zhang X., Arumugam S., Young LEA, Sun R.C., Clem B.F. Loss of Rb1 Enhances Glycolytic Metabolism in Kras-Driven Lung Tumors In Vivo. ancers (Basel). 2020 Jan 17;12(1). pii: E237.
DOI: 10.3390/cancers12010237.

D

Dai X.Z., Wang L.Y., Shan Y., Qian J., Xue K., Ye J. Clinicopathological analysis of 719 pediatric and adolescents' ocular tumors and tumor-like lesions: a retrospective study from 2000 to 2018 in China. International journal of ophthalmology. 2020 Dec 18;13(12):1961-1967.
doi: 10.18240/ijo.2020.12.18.
https://pubmed.ncbi.nlm.nih.gov/33344197/

Dalvi N., Kleinerman R.A., Epelman S., Abramson D.H., Dunkel I.J. Low-grade glioma: A rare second tumor in retinoblastoma survivors. Pediatric blood & cancer. 2020 Oct 16.
doi: 10.1002/pbc.28770.
https://pubmed.ncbi.nlm.nih.gov/33063942/

Dalvin L.A., Bas Z., Tadepalli S., Rao R., Vaidya S., Pacheco R., Shields C.L. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients. Journal of pediatric ophthalmology and strabismus. 2020 Jul 1.
doi: 10.3928/01913913-20200417-01.
https://pubmed.ncbi.nlm.nih.gov/32687206/

Daniels A.B., Patel S.N., Milam R.W., Kohanim S., Friedman D.L., Koyama T.
Effect of Intravenous Chemotherapy Regimen on Globe Salvage Success Rates for Retinoblastoma Based on Disease Class-A Meta-Analysis. Cancers (Basel). 2021;13(9):2216. 2021 May 6.
doi:10.3390/cancers13092216
https://pubmed.ncbi.nlm.nih.gov/34066325/

Das A., Ranjan R., Shah P.K. Coexistent Retinoblastoma and Retinopathy of Prematurity in a Preterm Infant.
https://pubmed.ncbi.nlm.nih.gov/33339056/

Davies H.R., Broad K.D., Onadim Z., Price E.A., Zou X., Sheriff I., Karaa E.K., Scheimberg I., Reddy M.A., Sagoo M.S., Ohnuma S.I., Nik-Zainal S. Whole-Genome Sequencing of Retinoblastoma Reveals the Diversity of Rearrangements Disrupting RB1 and Uncovers a Treatment-Related Mutational Signature. Cancers. 2021 Feb 11;13(4):754.
doi: 10.3390/cancers13040754.
https://pubmed.ncbi.nlm.nih.gov/33670346/

Del Carmen Bernal-Díaz Z., Murillo-Maldonado M.A., Pérez-Villanueva H., Reyes-López A., Ramírez-Ortiz M.A. Ocular preservation in patients with bilateral retinoblastoma before chemotherapy in situ era: A report from a Mexican Retinoblastoma Reference Hospital. Pediatric blood & cancer. 2020 Aug 3
doi: 10.1002/pbc.28625.
https://pubmed.ncbi.nlm.nih.gov/32743978/

Delrish E., Jabbarvand M., Ghassemi F., Amoli F.A., Atyabi F., Lashay A., Soleimani M., Aghajanpour L., Dinarvand R. Efficacy of topotecan nanoparticles for intravitreal chemotherapy of retinoblastoma.
Experimental eye research. 2021 Jan 13;204:108423.
doi: 10.1016/j.exer.2020.108423.
https://pubmed.ncbi.nlm.nih.gov/33453276/

Demirci H., Wang Y., Li Q., Lin C.M., Kotov N.A., Grisolia A.B.D., Guo J.L.
Penetration of Carbon Nanotubes into the Retinoblastoma Tumor after Intravitreal Injection in LH BETA T AG Transgenic Mice Reti-noblastoma Model.
Journal of ophthalmic & vision research. 2020 Oct 25;15(4):446-452.
doi: 10.18502/jovr.v15i4.7778.
https://pubmed.ncbi.nlm.nih.gov/33133434/

Dhingra H., Arya D., Taluja A., Das S., Mahajan A. A study analyzing the health-related quality of life of retinoblastoma survivors in India. Indian journal of ophthalmology. 2021 Jun;69(6):1482-1486.
doi: 10.4103/ijo.IJO_2428_20.
https://pubmed.ncbi.nlm.nih.gov/34011724/

Ding F., Jiang K., Sheng Y., Li C., Zhu H. LncRNA MIR7-3HG executes a positive role in retinoblastoma progression via modulating miR-27a-3p/PEG10 axis. Exp Eye Res. 2020 Feb 5;193:107960.
DOI: 10.1016/j.exer.2020.107960

Dittner-Moormann S., Reschke M., Abbink F.C.H., Aerts I., Atalay H.T., Fedorovna Bobrova N., Biewald E., Brecht IB, Caspi S, Cassoux N., Castela G., Diarra Y., Duncan C., Ebinger M., Garcia Aldana D., Hadjistilianou D., Kepák T., Klett A., Kiratli H., Maka E., Opocher E., Pawinska-Wasikowska K., Rascon J., Russo I., Rutynowska-Pronicka O., Sábado Álvarez C., Pacheco S.S.R., Svojgr K., Timmermann B., Vishnevskia-Dai V., Eggert A., Ritter-Sovinz P., Bechrakis N.E., Jenkinson H., Moll A., Munier F.L., Popovic M.B., Chantada G., Doz F., Ketteler P. Adjuvant therapy of histopathological risk factors of retinoblastoma in Europe: A survey by the European Retinoblastoma Group (EURbG). Pediatric blood & cancer. 2021 Mar 15:e28963.
doi: 10.1002/pbc.28963.
https://pubmed.ncbi.nlm.nih.gov/33720495/

Deng X., Cheng Y., Zhu X.M., Linghu D.D., Zhao M.W., Liang J.H. [Evaluation the risk of optic nerve invasion associated with optic nerve obscuration in advanced retinoblastoma]. Chinese journal of ophthalmology. 2020 Sep 11.
doi: 10.3760/cma.j.cn112142-20200318-00197.

Domínguez-Varela I.A., Aguilera-Partida J.A., Dalvin L.A., Garza-Garza L.A., Thompson-García L.M., Barbosa-Quintana Á., Ancona-Lezama D. Retinoblastoma in an older Hispanic child masquerading as pars planitis: A case report.
European journal of ophthalmology. 2021 Feb 10:1120672121994487.
doi: 10.1177/1120672121994487.
https://pubmed.ncbi.nlm.nih.gov/33567900/

Dong Y., Wan G., Yan P., Qian C., Li F., Peng G. Long noncoding RNA LINC00324 promotes retinoblastoma progression by acting as a competing endogenous RNA for microRNA-769-5p, thereby increasing STAT3 expression. Aging. 2020 May 5
DOI: 10.18632/aging.103075
https://pubmed.ncbi.nlm.nih.gov/32369777/?from_term=retinoblastoma&from_sort=date&from_page=5&from_pos=4

Döpper H., Horstmann M., Menges J., Bozet M., Kanber D., Steenpass L. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines. Stem Cell Research. 2020 Mar 29;45:101779.
DOI: 10.1016/j.scr.2020.101779.
https://pubmed.ncbi.nlm.nih.gov/32268247/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=2

E

Echegaray J.J., Al-Zahrani Y.A., Singh A. Episcleral brachytherapy for retinoblastoma. Br J Ophthalmol 2020; 104(2):208–13.
doi: 10.1136/bjophthalmol-2019-313985
https://pubmed.ncbi.nlm.nih.gov/31122912/

El Hamichi S., Acon D., Kon Graversen V., Gold A.S., Berrocal A.M., Murray T.G.
Acute Orbital Compromise after Intra-Arterial Chemotherapy in a Complex Retinoblastoma Associated with 13q Deletion Syndrome. Pediatric Neurosurgery. 2020 Nov 11:1-4.
doi: 10.1159/000511019.
https://pubmed.ncbi.nlm.nih.gov/33176321/

El Zomor H., Nour R., Saad A., Taha H., Shelil A.E., Aleieldin A., Saad Zaghloul M., Alfaar A.S. Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients. Eye. 2020 Nov 13.
doi: 10.1038/s41433-020-01275-2.
https://pubmed.ncbi.nlm.nih.gov/33188294/

Eulo V., Lesmana H., Doyle L.A., Nichols K.E., Hirbe A.C. Secondary Sarcomas: Biology, Presentation, and Clinical Care. // American Society of Clinical Oncology. 2020 Mar.
DOI: 10.1200/EDBK_280985. PMID: 32213089
https://pubmed.ncbi.nlm.nih.gov/32213089/?from_term=retinoblastoma&from_sort=date&from_pos=1

F

Fabian I.D., Stacey A.W., Bowman R., Khetan V., Blum S., Keren-Froim N., Staffieri S., Foster A.; Global Retinoblastoma Study Group. Retinoblastoma management during the COVID-19 pandemic: A report by the Global Retinoblastoma Study Group including 194 centers from 94 countries. Pediatric blood & cancer. 2020 Aug 6
doi: 10.1002/pbc.28584.
https://pubmed.ncbi.nlm.nih.gov/32762025/

Fabian I.D., Stacey A.W., Foster A., Kivelä T.T., Munier F.L. etc. Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries. The British journal of ophthalmology. 2020 Sep 15.
doi: 10.1136/bjophthalmol-2020-316613.
https://pubmed.ncbi.nlm.nih.gov/32933936/

Fabius A.W.M., van Hoefen Wijsard M., van Leeuwen F.E., Moll A.C. Subsequent Malignant Neoplasms in Retinoblastoma Survivors. Cancers. 2021 Mar 10;13(6):1200.
doi: 10.3390/cancers13061200.
https://pubmed.ncbi.nlm.nih.gov/33801943/

Fang X., Chen J., Wang Y., Zhao M., Zhang X., Yang L., Ni X., Zhao J., Gallie B.L. RB1 germline mutation spectrum and clinical features in patients with unilateral retinoblastomas. Ophthalmic genetics. 2021 Jun 30:1-7.
doi: 10.1080/13816810.2021.1946703.
https://pubmed.ncbi.nlm.nih.gov/34190019/

Fang X., Wang H., Ma X., Guo Y., Yang W., Hu S., Qiu Y., Zhao J., Ni X. Clinical Features of Children with Retinoblastoma and Neuroblastoma. Journal of ophthalmology. 2020 Jul 10.
doi: 10.1155/2020/9315784
https://pubmed.ncbi.nlm.nih.gov/32695501/

Fang X., Wang Y., Yin J., Guo Y., Jia L., Zhang C., Jin M., Ni X., Zhao J. Clinical features and survival of Chinese children with trilateral retinoblastoma during 2006-2019: A retrospective multicenter study. American journal of ophthalmology. 2020 Oct 10.
doi: 10.1016/j.ajo.2020.10.002.
https://pubmed.ncbi.nlm.nih.gov/33049241/

Faranoush M., Mehrvar N., Tashvighi M., Fabian I.D., Zloto O., Bascaran C., Ghorbani R., Ghasemi F., Naseripour M., Sedaghat A., Alebouyeh M., Mehrvar A. Retinoblastoma presentation, treatment and outcome in a large referral centre in Tehran: a 10-year retrospective analysis. Eye. 2020 May 4
DOI: 10.1038/s41433-020-0907-z
https://pubmed.ncbi.nlm.nih.gov/32367000/?from_term=retinoblastoma&from_sort=date&from_page=5&from_pos=6

Farouk Sait S., Haque S., Karimi S., Rebeiz K.J., Francis J.H., Marr B.P., Abramson D.H., Souweidane M.M., Dunkel I.J. A Potential Role For Apparent Diffusion Coefficient in the Diagnosis of Trilateral Retinoblastoma. Journal of Pediatric Hematology/Oncology. 2020 Apr
DOI: 10.1097/MPH.0000000000001523
https://pubmed.ncbi.nlm.nih.gov/31259824/?from_term=retinoblastoma&from_sort=pubdate&from_size=50&from_pos=14

Feng W., Zhu R., Ma J., Song H. LncRNA ELFN1-AS1 Promotes Retinoblastoma Growth and Invasion via Regulating miR-4270/SBK1 Axis. Cancer management and research. 2021 Feb 5;13:1067-1073.
doi: 10.2147/CMAR.S281536.
https://pubmed.ncbi.nlm.nih.gov/33574704/

Feng Y., Zhou C., Jia R., Wang Y., Fan X.Quality of Life (QoL) and Psychosocial Outcomes in Adult Survivors of Unilateral Retinoblastoma (RB) in China. Journal of Ophthalmology. 2020 Mar 12
DOI: 10.1155/2020/4384251
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125462/

Flegg K., Gelkopf M.J., Johnson S.A., Dimaras H.; Canadian Retinoblastoma Research Advisory Board Priority Setting Steering Committee. The top 10 retinoblastoma research priorities in Canada as determined by patients, clinicians and researchers: a patient-oriented priority-setting partnership. CMAJ open. 2020 Jun 9.
doi: 10.9778/cmajo.20190221
https://pubmed.ncbi.nlm.nih.gov/32518094/

De Francesco S., Galluzzi P., Bracco S., Di Maggio A., Sgheri A., Hadijstilianou T.
Rescue intra-arterial chemotherapy in unilateral multirelapsed peripapillary retinoblastoma: Decision making and the role of MRI. European journal of ophthalmology. 2020 Sep 9.
doi: 10.1177/1120672120957586.
https://pubmed.ncbi.nlm.nih.gov/32907373/

De Francesco S., Sgheri A., Di Maggio A., Rana F., Anna Maria P., Alessandra R., Hadjistilianou T. Bilateral Retinoblastoma and Osteogenesis Imperfecta, a Very Rare Association: Two Cases. European Journal of Ophthalmology. 2020 Apr 21.
DOI: 10.1177/1120672120919344
https://pubmed.ncbi.nlm.nih.gov/32314604/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=3

Francis J.H., Richards A.L., Mandelker D.L., Berger M.F., Walsh M.F., Dunkel I.J., Donoghue M.T.A, Abramson D.H. Molecular Changes in Retinoblastoma beyond RB1: Findings from Next-Generation Sequencing. Cancers. 2021 Jan 5;13(1):149.
doi: 10.3390/cancers13010149.
https://pubmed.ncbi.nlm.nih.gov/33466343/

Friedman D.N., Hsu M., Moskowitz C.S., Francis J.H., Lis E., Fleischut M.H., Oeffinger K.C., Walsh M., Tonorezos E.S., Sklar C.A., Abramson D.H., Dunkel I. Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: An update. J. Pediatr Blood Cancer. 2020 Jul;67(7):e28389. Epub 2020 May 9.
doi: 10.1002/pbc.28389.
PMID: 32386119

Friedman E.L., Froehler M.T., Daniels A.B. Orbital Swelling in a Child With Retinoblastoma Following Intra-arterial Chemotherapy. JAMA Ophthalmology. 2021 Jan 21.
doi: 10.1001/jamaophthalmol.2020.4675.
https://pubmed.ncbi.nlm.nih.gov/33475694/

Froehler M.T., Feldman M.J., Poitras B., Daniels A.B. Angiographic investigation of orbital vascular variations in the rabbit and implications for endovascular intra-arterial chemotherapy models. Journal of neurointerventional surgery. 2020 Sep 11
doi: 10.1136/neurintsurg-2020-016460.
https://pubmed.ncbi.nlm.nih.gov/32917761/

Fu C., Wang S., Jin L., Zhang M., Li M. CircTET1 inhibits retinoblastoma progression via targeting miR-492 and miR-494-3p through Wnt/beta-catenin signaling pathway. Current eye research. 2020 Oct 27.
doi: 10.1080/02713683.2020.1843685. https://pubmed.ncbi.nlm.nih.gov/33108919/

Fu C., Wang S., Jin L., Zhang M., Li M. CircTET1 Inhibits Retinoblastoma Progression via Targeting miR-492 and miR-494-3p through Wnt/β-catenin Signaling Pathway. Current eye research. 2021 May 7:1-10.
doi: 10.1080/02713683.2020.1843685.
https://pubmed.ncbi.nlm.nih.gov/33108919/

G

Galardi A., Colletti M., Lavarello C., Di Paolo V., Mascio P., Russo I., Cozza R., Romanzo A., Valente P., De Vito R., Pascucci L., Peinado H., Carcaboso A.M., Petretto A., Locatelli F., Di Giannatale A. Proteomic Profiling of Retinoblastoma-Derived Exosomes Reveals Potential. Biomarkers of Vitreous Seeding. Cancers. 2020 Jun 12.
doi: 10.3390/cancers12061555.
https://pubmed.ncbi.nlm.nih.gov/32545553/

Gallo R.A., Shoag J., Johnson T.E., Solomon D.A., Perry A., Podda A., Lee J.Y., Rong A. Eye-sparing Treatment of Localized Orbital Medulloepithelioma With Neoadjuvant Chemoradiation. J. Ophthalmic Plast Reconstr Surg. 2020 May 14.
doi: 10.1097/IOP.0000000000001703
Online ahead of print. PMID: 32427730

Ganesan B., Parameswaran S., Sharma A., Krishnakumar S. Clinical relevance of B7H3 expression in retinoblastoma. Scientific reports. 2020 Jun 23.
doi: 10.1038/s41598-020-67101-7.
https://pubmed.ncbi.nlm.nih.gov/32576886/

Gao M., Cui Z., Zhao D., Zhang S., Cai Q. MicroRNA-9 inhibits proliferation and progression in retinoblastoma cells by targeting PTEN. Genes & genomics. 2021 Jun 15.
doi: 10.1007/s13258-021-01043-w.
https://pubmed.ncbi.nlm.nih.gov/34129195/

Gao X., Jin Z., Tan X., Zhang C., Zou C., Zhang W., Ding J., Das B.C., Severinov K., Hitzeroth I.I., Debata P.R., He D., Ma X., Tian X., Gao Q., Wu J., Tian R., Cui Z., Fan W., Huang Z., Cao C., Bao Y., Tan S., Hu Z. Hyperbranched poly (β-amino ester) based polyplex nanopaticles for delivery of CRISPR/Cas9 system and treatment of HPV infection associated cervical cancer. J Control Release. 2020 Feb 27.
DOI: 10.1016/j.jconrel.2020.02.045

Gao Y., Luo X., Zhang J. LincRNA-ROR is activated by H3K27 acetylation and induces EMT in retinoblastoma by acting as a sponge of miR-32 to activate the Notch signaling pathway. Cancer gene therapy. 2020 May 22
DOI: 10.1038/s41417-020-0181-z
https://pubmed.ncbi.nlm.nih.gov/32439866/?from_term=retinoblastoma&from_sort=date&from_pos=7

Gao Y., Luo X., Zhang J. Sp1-mediated up-regulation of lnc00152 promotes invasion and metastasis of retinoblastoma cells via the miR-30d/SOX9/ZEB2 pathway. Cellular oncology (Dordrecht). 2020 Jun 1.
doi: 10.1007/s13402-020-00522-8
https://pubmed.ncbi.nlm.nih.gov/32488851/

Gao Y.X., Gao H.X., Xu X.Y., Ding F.K. Effects of lncRNA MALAT1 and lncRNA NKILA on proliferation, invasion and apoptosis of retinoblastoma. European review for medical and pharmacological sciences. 2020 Aug;24
doi: 10.26355/eurrev_202008_22626.
https://pubmed.ncbi.nlm.nih.gov/32894536/

Garza-Garza L.A., Ruiz-Lozano R.E., Rebolledo-Méndez G., Ibarra-Nava I., Morales-Garza H.J., Ancona-Lezama D. Challenge of Retinoblastoma in Mexico in 2020: Perspectives and Solutions. Journal of ophthalmology. 2020 Aug 10
doi: 10.1155/2020/1953602
https://pubmed.ncbi.nlm.nih.gov/32850140/

Geng W., Ren J., Shi H., Qin F., Xu X., Xiao S., Jiao Y., Wang A. RPL41 sensitizes retinoblastoma cells to chemotherapeutic drugs via ATF4 degradation. Journal of cellular physiology. 2020 Aug 11.
doi: 10.1002/jcp.30010.
https://pubmed.ncbi.nlm.nih.gov/32783256/

Gerrish A., Bowns B., Mashayamombe-Wolfgarten C., Young E., Court S., Bott J., McCalla M., Ramsden S., Parks M., Goudie D., Carless S., Clokie S., Cole T., Allen S. Non-Invasive Prenatal Diagnosis of Retinoblastoma Inheritance by Combined Targeted Sequencing Strategies. Journal of Clinical Medicine. 2020 Oct 30;9(11):3517.
doi: 10.3390/jcm9113517.
https://pubmed.ncbi.nlm.nih.gov/33143217/

Gerrish A., Jenkinson H., Cole T. The Impact of Cell-Free DNA Analysis on the Management of Retinoblastoma. Cancers. 2021 Mar 29;13(7):1570.
doi: 10.3390/cancers13071570.
https://pubmed.ncbi.nlm.nih.gov/33805427/

Ghafouri-Fard S., Dashti S., Taheri M., Omrani M.D. TINCR: An lncRNA with dual functions in the carcinogenesis process. Non-coding RNA research. 2020 Jul 9.
doi: 10.1016/j.ncrna.2020.06.003.
https://pubmed.ncbi.nlm.nih.gov/32695943/

Global Retinoblastoma Study Group. Global Retinoblastoma Presentation and Analysis by National Income Level. JAMA Oncology. Published Online: February 27, 2020.
DOI:10.1001/jamaoncol.2019.6716

Gohari M., Moghimi M., Aarafi H., Shajari A., Jafari-Nedooshan J., Lookzadeh MH., Mirjalili SR., Neamatzadeh H. Association of MTHFR 677C > T, 1298A > C and MTR 2756A > G Polymorphisms with Susceptibility to Childhood Retinoblastoma: A Systematic Review and Met-Analysis. Fetal and Pediatric Pathology. Feb-2020.
DOI 10.1080/15513815.2020.1721738

Goncalves L.F., Ramasubramanian A., Grebe T., Riemann M., Moncrief D., Cornejo P. Prenatal diagnosis of bilateral retinoblastomas by multimodality fetal imaging: case report and review of the literature. Clinical imaging. 2021 Mar 20;78:121-126.
doi: 10.1016/j.clinimag.2021.03.023.
https://pubmed.ncbi.nlm.nih.gov/33774578/

Gregersen P.A., Olsen M.H., Urbak S.F., Funding M., Dalton S.O., Overgaard J., Alsner J. Incidence and Mortality of Second Primary Cancers in Danish Patients With Retinoblastoma, 1943-2013. JAMA Network Open. 2020 Oct 1
doi: 10.1001/jamanetworkopen.2020.22126.
https://pubmed.ncbi.nlm.nih.gov/33090227/

Guihurt Santiago J., Burgos-Tirado N., Lafontaine D.D., Mendoza Sierra J.C., Camacho R.H., Vecchini Rodríguez C.M., Morales-Tirado V., Flores-Otero J. Adhesion G protein-coupled receptor, ELTD1, is a potential therapeutic target for retinoblastoma migration and invasion. BMC Cancer. 2021 Jan 11;21(1):53.
doi: 10.1186/s12885-020-07768-3.
https://pubmed.ncbi.nlm.nih.gov/33430814/

Gui T., Zheng H., Liu M., Xia Z., Ji X., Yin Q., Wang D., Li Y., Chen S. Clinical and magnetic resonance imaging features of 14 patients with trilateral retinoblastoma. Quantitative imaging in medicine and surgery. Quantitative imaging in medicine and surgery. 2021 Apr;11(4):1458-1469.
doi: 10.21037/qims-20-605.
https://pubmed.ncbi.nlm.nih.gov/33816182/

Guiying T., Yue L., Chao X., Jinhai Y., Qihua X. Retracted: Antitumor Effects of 8-Deoxylactucin in RB355 Human Retinoblastoma Cells Are Mediated via Apoptosis Induction, Reactive Oxygen Species Production, and Cell Cycle Arrest. Medical science monitor : international medical journal of experimental and clinical research. 2021 Mar 25;27:e932344.
doi: 10.12659/MSM.932344.
https://pubmed.ncbi.nlm.nih.gov/33762557/

Gündüz A.K., Mirzayev I., Temel E., Ünal E., Taçyıldız N., Dinçaslan H., Köse S.K., Özalp Ateş F.S., Işık M.U. A 20-year audit of retinoblastoma treatment outcomes. Eye. 2020 May 6.
DOI: 10.1038/s41433-020-0898-9
https://pubmed.ncbi.nlm.nih.gov/32376976/?from_term=retinoblastoma&from_sort=date&from_page=5&from_pos=2

Gündüz A.K., Mirzayev I., Temel E., Ünal E., Taçyıldız N., Dinçaslan H., Köse S.K., Ateş F.S.Ö., Işık M.U. Correction: A 20-year audit of retinoblastoma treatment outcomes. Eye. 2020 Aug 5.
doi: 10.1038/s41433-020-1119-2.
https://pubmed.ncbi.nlm.nih.gov/32760009/

Gupta A.K., Meena J.P., Seth R. Reasons for missed chemotherapy appointments in retinoblastoma patients undergoing chemotherapy: A report from a Tertiary Care Hospital from India. Cancer reports. 2020 Sep 3
doi: 10.1002/cnr2.1279.
https://pubmed.ncbi.nlm.nih.gov/32881413/
H

Hadjistilianou D., Barchitta M., Defrancesco S. Covid-19 and retinoblastoma: How we manage it. European journal of ophthalmology. 2020 Jun 19.
doi: 10.1177/1120672120936484
https://pubmed.ncbi.nlm.nih.gov/32552159/

Hanbazazh M., Dryja T.P. Molecular Genetics of Intraocular Tumors. Seminars in ophthalmology. 2020 Jun 7.
doi: 10.1080/08820538.2020.1776343
https://pubmed.ncbi.nlm.nih.gov/32507011/

Handayani K., Indraswari B.W., Sitaresmi M.N., Mulatsih S., Widjajanto P.H., Kors W.A., Kaspers G.J., Mostert S. Treatment Outcome of Children with Retinoblastoma in a Tertiary Care Referral Hospital in Indonesia. Asian Pacific journal of cancer prevention : APJCP. 2021 May 1;22(5):1613-1621.
doi:10.31557/APJCP.2021.22.5.1613
https://pubmed.ncbi.nlm.nih.gov/34048193/

Han S., Song L., Chen Y., Hou M., Wei X., Fan D. The long non-coding RNA ILF3-AS1 increases the proliferation and invasion of retinoblastoma through the miR-132-3p/SMAD2 axis. Experimental cell research. 2020 May 11.
DOI: 10.1016/j.yexcr.2020.112087
https://pubmed.ncbi.nlm.nih.gov/32407730/?from_term=retinoblastoma&from_sort=date&from_page=3&from_pos=7

He X., Chai P., Li F., Zhang L., Zhou C., Yuan X., Li Y., Yang J., Luo Y., Ge S., Zhang H., Jia R., Fan X. A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3. Molecular cancer. 2020 Jul 15.
doi: 10.1186/s12943-020-01232-3.
https://pubmed.ncbi.nlm.nih.gov/32669100/

Hobzova R., Kodetova M., Pochop P., Uhlik J., Dunovska K., Svojgr K., Hrabeta J., Feriancikova B., Cocarta A.I., Sirc J. Hydrogel implants for transscleral diffusion delivery of topotecan: In vivo proof of concept in a rabbit eye model. International journal of pharmaceutics. 2021 Jun 24:120832.
doi: 10.1016/j.ijpharm.2021.120832.
https://pubmed.ncbi.nlm.nih.gov/34175379/

Hsieh T., Liao A., Francis J.H., Lavery J.A., Mauguen A., Brodie S.E., Abramson D.H. Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma. PLoS One. 2020 Jul 1.
doi: 10.1371/journal.pone.0235016.
https://pubmed.ncbi.nlm.nih.gov/32609726/

Huang J., Zhang L., Li Z., Lu X. Screening and identification of key biomarkers for retinoblastoma: Evidence from bioinformatics analysis. Medicine (Baltimore) 2020 May.
DOI: 10.1097/MD.0000000000019952
https://pubmed.ncbi.nlm.nih.gov/32443297/?from_term=retinoblastoma&from_sort=date&from_pos=5

Huang Y., Xue B., Pan J., Shen N. Circ-E2F3 acts as a ceRNA for miR-204-5p to promote proliferation, metastasis and apoptosis inhibition in retinoblastoma by regulating ROCK1 expression. Experimental and molecular pathology. 2021 Apr 18;120:104637.
doi: 10.1016/j.yexmp.2021.104637.
https://pubmed.ncbi.nlm.nih.gov/33844975/

Hülsenbeck I., Frank M., Biewald E., Kanber D., Lohmann D.R., Ketteler P.
Introduction of a Variant Classification System for Analysis of Genotype-Phenotype Relationships in Heritable Retinoblastoma. Cancers. 2021 Mar 31;13(7):1605.
doi: 10.3390/cancers13071605.
https://pubmed.ncbi.nlm.nih.gov/33807189/

Hussain Z. Impact of Laterality on Cumulative Survival in Patients Diagnosed with Retinoblastoma: A Retrospective Cohort Analysis of 1925 Cases in the Surveillance, Epidemiology, and End Results (SEER) Program. Clinical ophthalmology. 2021 Mar 5;15:991-1001.
doi: 10.2147/OPTH.S298209. eCollection 2021.
https://pubmed.ncbi.nlm.nih.gov/33707938/

Hu Y., Zhao M., Li L., Ding J., Gui Y.M., Wei T.W. miR-491-3p is Downregulated in Retinoblastoma and Inhibit Tumor Cells Growth and Metastasis by Targeting SNN. Biochemical genetics. 2020 Oct 23.
doi: 10.1007/s10528-020-10007-w.
https://pubmed.ncbi.nlm.nih.gov/33098307/


I

Ishaq H., Patel B.C. Cancer, Retinoblastoma. 2020 Aug 10. StatPearls [Internet].
https://pubmed.ncbi.nlm.nih.gov/31424860/

J

Jakati S., Patel A., Pathengay A., Kaliki S. Coincidental Retinal Dysplasia in Patients Presenting With Pseudohypopyon: A Series of Two Cases. BMJ Case Reports.
DOI: 10.1136/bcr-2019-233922
https://pubmed.ncbi.nlm.nih.gov/32300034/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=7

Janic A., Bowden S., Levy S., Stinson J., Dimaras H. Patient-reported outcome measures for retinoblastoma: a scoping review. Journal of patient-reported outcomes. 2020 Aug 8.
doi: 10.1186/s41687-020-00232-7.
https://pubmed.ncbi.nlm.nih.gov/32770435/

Jansen R.W., de Bloeme C.M., Brisse H.J., Galluzzi P., Cardoen L., Göricke S., Maeder P., Cassoux N., Gauthier A., Schlueter S., Hadjistilianou T., Munier F.L., Castelijns J.A., van der Valk P., Moll A.C., de Jong M.C., de Graaf P. MR Imaging Features to Differentiate Retinoblastoma from Coats' Disease and Persistent Fetal Vasculature. Cancers. 2020 Nov 30;12(12):3592.
doi: 10.3390/cancers12123592.
https://pubmed.ncbi.nlm.nih.gov/33266342/

Jiang Y., Xiao F., Wang L., Wang T., Chen L. Circular RNA has_circ_0000034 accelerates retinoblastoma advancement through the miR-361-3p/ADAM19 axis. Molecular and cellular biochemistry. 2020 Aug 25.
doi: 10.1007/s11010-020-03886-5.
https://pubmed.ncbi.nlm.nih.gov/32844346/

Jiang Y., Xiao F., Wang L., Wang T., Chen L. Hsa_circ_0099,198 facilitates the progression of retinoblastoma by regulating miR-1287/LRP6 axis. Experimental eye research. 2021 Mar 4;206:108529.
doi: 10.1016/j.exer.2021.108529.
https://pubmed.ncbi.nlm.nih.gov/33676964/

Jia S., Wen X., Zhou M., He X., Han M., Fan J., Jia R., Fan X. Comparison of Intra-Arterial Chemotherapy Efficacy Delivered Through the Ophthalmic Artery or External Carotid Artery in a Cohort of Retinoblastoma Patients. Frontiers in medicine. 2021 Jun 11;8:658305.
doi: 10.3389/fmed.2021.658305.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225945/

Jiménez I., Laé M, Tanguy M.L., Savignoni A., Gauthier-Villars M., Desjardins L., Cassoux N., Dendale R., Rodriguez J., Doz F., Brisse H.J., Aerts I. Craniofacial second primary tumors in patients with germline retinoblastoma previously treated with external beam radiotherapy: A retrospective institutional analysis. Pediatr Blood Cancer. 2020 Jan
DOI: 10.1002/pbc.28158.

Jo D.H., Lee S., Bak E., Cho C.S., Han Y.T., Kim K., Suh Y.G., Kim J.H. Anti-tumor Activity of Novel STAT3 Inhibitors on Retinoblastoma. Molecular Pharmacology. 2021 May 20:MOLPHARM-AR-2020-000231.
doi: 10.1124/molpharm.120.000231.
https://pubmed.ncbi.nlm.nih.gov/34016717/

de Jong M.C., Shaikh F., Gallie B., Kors W.A., Jansen R.W,. Dommering C., de Graaf P., Moll A.C., Dimaras H., Shroff M., Kivelä T.T., Soliman S.E. Asynchronous pineoblastoma is more likely after early diagnosis of retinoblastoma: a meta-analysis. Acta Ophthalmologica. 2021 May 3.
doi: 10.1111/aos.14855.
https://pubmed.ncbi.nlm.nih.gov/33939299/

de Jong M.C., Van Der Valk P., Jansen R.W., Abbink F., Bosscha M., Castelijns J.A., Moll A.C., de Graaf P. Full-width postlaminar optic nerve tumor invasion of retinoblastoma as risk-factor for leptomeningeal spread of retinoblastoma. A case report and review of the literature. Ophthalmic Genet. 2020 Feb 19:1-4.
DOI:10.1080/13816810.2020.1727535.

Jubran R.F., Villablanca J.G., Krailo M., Piao J., Huang L., Murphree A.L., O'Brien J., Gombos D., Shields C.L., Meadows A., Chintagumpala M. A Single-Arm Study of Systemic and sub-Tenon Chemotherapy for Groups C and D Intraocular Retinoblastoma: A Children's Oncology Group Study (ARET 0231). Pediatric Blood & Cancer. 2020 June 26.
doi: 10.1002/pbc.28502
https://pubmed.ncbi.nlm.nih.gov/32589362/

K

Kaewkhaw R., Rojanaporn D. Retinoblastoma: Etiology, Modeling, and Treatment. Cancers. 2020 Aug 16
doi: 10.3390/cancers12082304.
https://pubmed.ncbi.nlm.nih.gov/32824373/

Kaliki S. Aqueous seeding in intraocular retinoblastoma: A review. Clinical & experimental ophthalmology. 2021 Jun 29.
doi: 10.1111/ceo.13964.
https://pubmed.ncbi.nlm.nih.gov/34185374/

Kaliki S., Ji X., Zou Y., Rashid R., Sultana S., Taju Sherief S., Cassoux N., Y Diaz Coronado R., Luis Garcia Leon J., López A.M.Z., Polyakov V.G., Ushakova T.L., Rani Roy S., Ahmad A., Al Harby L., Reddy M.A., Sagoo M.S., L. Berry J., Kim J., Polski A., Astbury N.J., Bascaran C., Blum S., Bowman R., Burton M.J., Foster A., Gomel N., Keren-Froim N., Madgar S., W. Stacey A., M. Steinberg D., Mohamed A., Zondervan M., Fabian I.D. Lag Time between Onset of First Symptom and Treatment of Retinoblastoma: An International Collaborative Study of 692 Patients from 10 Countries. Cancers. 2021 Apr 19;13(8):1956.
doi: 10.3390/cancers13081956.
https://pubmed.ncbi.nlm.nih.gov/33921566/

Kaliki S., Maniar A., Kekunnaya R. Cataract surgery in treated retinoblastoma eyes: A study of 29 eyes. European journal of ophthalmology. 2020 Jun 25.
doi: 10.1177/1120672120938575
https://pubmed.ncbi.nlm.nih.gov/32586135/

Kaliki S., Vempuluru V.S., Priya Y., Mohamed A. Risk factors for recurrent retinoblastoma after intravenous chemotherapy. International ophthalmology. 2021 Feb 20.
doi: 10.1007/s10792-021-01759-4.
https://pubmed.ncbi.nlm.nih.gov/33611762/

Kanukollu V.M., Tripathy K. Leukocoria. StatPearls [Internet]. 2020 Aug 16.
https://pubmed.ncbi.nlm.nih.gov/32809629/

Karimi S., Arabi A., Shahraki T., Safi S. Central Serous Chorioretinopathy in a Case of Regressed Familial Retinoblastoma. Journal of ophthalmic & vision research. 2020 Oct 25;15(4):559-564.
doi: 10.18502/jovr.v15i4.7802.
https://pubmed.ncbi.nlm.nih.gov/33133447/

Kashyap S., Singh L., Kumar N., Singh M.K., Pushker N., Bakhshi S., Sen S., Lomi N., Meel R., Chawla B. Combined association of massive choroidal and optic nerve invasion as a prognostic relevance in primary retinoblastoma: A 10-year study. Asia-Pacific journal of clinical oncology. 2020 Jul 25.
doi: 10.1111/ajco.13348
https://pubmed.ncbi.nlm.nih.gov/32710815/

Kashyap S., Singh L., Kumar N., Singh M.K., Pushker N., Bakhshi S., Sen S., Lomi N., Meel R., Chawla B. Combined association of massive choroidal and optic nerve invasion as a prognostic relevance in primary retinoblastoma: A 10-year study. Asia-Pacific journal of clinical oncology. 2021 Apr;17(2):e100-e108.
doi: 10.1111/ajco.13348.
https://pubmed.ncbi.nlm.nih.gov/32710815/

Ketteler P., Hülsenbeck I., Frank M., Schmidt B., Jöckel K.H., Lohmann D.R. The impact of RB1 genotype on incidence of second tumours in heritable retinoblastoma. European journal of cancer. 2020 May 17.
DOI: 10.1016/j.ejca.2020.04.005
https://pubmed.ncbi.nlm.nih.gov/32434110/?from_term=retinoblastoma&from_sort=date&from_pos=10

Khoo S.A., Ong G.Y. Use of Ocular Point-of-Care Ultrasound in a Difficult Pediatric Examination: A Case Report of an Emergency Department Diagnosis of Retinoblastoma. // The Journal of Emergency Medicine. 2020 Mar.
DOI: 10.1016/j.jemermed.2020.01.006.
https://pubmed.ncbi.nlm.nih.gov/32204994/?from_term=retinoblastoma&from_sort=date&from_pos=4

Kim C.H., Kim M.J., Park J., Kim J., Kim J.Y., An M.J., Shin G.S., Lee H.M., Kim J.W.
Bisphenol A Exposure Changes the Transcriptomic and Proteomic Dynamics of Human Retinoblastoma Y79 Cells. Genes. 2021 Feb 11;12(2):264.
doi: 10.3390/genes12020264.
https://pubmed.ncbi.nlm.nih.gov/33670352/

Kim D.I., Lee H., Kwon S.H., Sung Y.J., Song W.K., Park S. Bilayer Hydrogel Sheet-Type Intraocular Microrobot for Drug Delivery and Magnetic Nanoparticles Retrieval. Advanced healthcare materials. 2020 May 19.
DOI: 10.1002/adhm.202000118
https://pubmed.ncbi.nlm.nih.gov/32431072/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=3

Kim H.A., Yoon Y.H., Kim J.G., Lee J.Y. Clinical Features and Long-term Prognosis of Retinoblastoma according to Age at Diagnosis. Korean journal of ophthalmology : KJO. 2020 Jun.
doi: 10.3341/kjo.2019.0097.
https://pubmed.ncbi.nlm.nih.gov/32495533/

Kim H.J., Di Nicola M., Augsburger J.J., Williams B.K. Successful salvage intravenous chemotherapy after tandem selective ophthalmic artery infusion chemotherapy in bilateral retinoblastoma. Indian journal of ophthalmology. 2020 Nov;68(11):2618-2620.
doi: 10.4103/ijo.IJO_576_20.
https://pubmed.ncbi.nlm.nih.gov/33120714/

King B.A., Sahr N., Sykes A., Wilson M.W., Brennan R.C. Chemoreduction with topotecan and vincristine: Quantifying tumor response in bilateral retinoblastoma patients. Pediatric blood & cancer. 2021 Jan 28:e28882.
doi: 10.1002/pbc.28882.
https://pubmed.ncbi.nlm.nih.gov/33507604/

King B.A., Sahr N., Sykes A., Wilson M.W., Brennan R.C. Chemoreduction with topotecan and vincristine: Quantifying tumor response in bilateral retinoblastoma patients. Pediatric blood & cancer. 2021 Apr;68(4):e28882.
doi: 10.1002/pbc.28882.
https://pubmed.ncbi.nlm.nih.gov/33507604/

Kiratli H., Koç I., Öztürk E., Varan A., Akyüz C. Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma. Japanese journal of ophthalmology. 2020 May 23.
DOI: 10.1007/s10384-020-00743-2
https://pubmed.ncbi.nlm.nih.gov/32447585/?from_term=retinoblastoma&from_sort=date&from_pos=4

Kleinerman R.A., Schonfeld S.J., Abramson D.H., Francis J.H., Seddon J.M., Morton L.M., Tucker M.A.
Increased risk of skin cancer in 1851 long-term retinoblastoma survivors. The Journal of investigative dermatology. 2021 Jun 18:S0022-202X(21)01334-8.
doi: 10.1016/j.jid.2021.05.021.
https://pubmed.ncbi.nlm.nih.gov/34153328/

Koç İ., Taylan Şekeroğlu H., Kıratlı H., Lotfisadigh S. Management of cataracts secondary to intravitreal chemotherapy injections for retinoblastoma seeding.European journal of ophthalmology. 2021 Jun 3:11206721211023317.
doi: 10.1177/11206721211023317.
https://pubmed.ncbi.nlm.nih.gov/34082595/

Kong L., Sun Y., Chen M., Dai Y., Liu Z. Downregulation of microRNA-320a inhibits proliferation and induces apoptosis of retinoblastoma cells via targeting TUSC3. Experimental and therapeutic medicine. 2020 Nov;20
doi: 10.3892/etm.2020.9137
https://pubmed.ncbi.nlm.nih.gov/32934674/

Kong M., Han Y., Zhao Y., Zhang H.
miR-512-3p Overcomes Resistance to Cisplatin in Retinoblastoma by Promoting Apoptosis Induced by Endoplasmic Reticulum Stress. Medical science monitor : international medical journal of experimental and clinical research. 2020 Jul 9.
doi: 10.12659/MSM.923817.
https://pubmed.ncbi.nlm.nih.gov/32641679/

Kothari P., Marass F., Yang J.L., Stewart C.M., Stephens D., Patel J., Hasan M., Jing X., Meng F., Enriquez J., Huberman K., Viale A., Francis J.H., Berger M.F., Shukla N., Abramson D.H., Dunkel I.J., Tsui D.W.Y. Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience. Cancer medicine. 2020 Jul 7.
doi: 10.1002/cam4.3144
https://pubmed.ncbi.nlm.nih.gov/32633890/

Kumar Panigrahi D. P. Correspondence on Turkoglu EB, Erol MK, Karaca BO, Coexistence of torpedo maculopathy and retinoblastoma: Differentiation the lesions with hand held optical coherence tomography, Photodiagnosis and photodynamic therapy 34 (2021) 102331. Photodiagnosis and photodynamic therapy, 102357. 26 May. 2021. doi:10.1016/j.pdpdt.2021.102357
https://pubmed.ncbi.nlm.nih.gov/34051344/

L

Lamiot A.K., Trone M.C., Garcin T., Pommier B., Thuret G., Gain P. [Orbital leiomyosarcoma post-irradiated hereditary retinoblastoma: A case study].
Journal français d'ophtalmologie. 2020 Dec 3:S0181-5512(20)30510-6.
doi: 10.1016/j.jfo.2020.04.046.
https://pubmed.ncbi.nlm.nih.gov/33280903/

Lande K., Gupta J., Ranjan R., Kiran M., Torres Solis L.F., Solís Herrera A., Aliev G., Karnati R. Exosomes: Insights from Retinoblastoma and Other Eye Cancers. International journal of molecular sciences. 2020 Sep 25
doi: 10.3390/ijms21197055.
https://pubmed.ncbi.nlm.nih.gov/32992741/

Lan X., Xu W., Tang X., Ye H., Song X., Lin L., Ren X., Yu G., Zhang H., Wu S. Spectrum of RB1 Germline Mutations and Clinical Features in Unrelated Chinese Patients With Retinoblastoma. // Frontiers in Genetics. 2020 Mar 11;
DOI: 10.3389/fgene.2020.00142.
https://pubmed.ncbi.nlm.nih.gov/32218800/?from_term=retinoblastoma&from_sort=date&from_pos=8

Lazari K. Papageorgiou E., Tsironi E.E., Androudi S. Late-onset retinoblastoma in a 12-year-old girl. Postgraduate medical journal. 2021 Feb 15:postgradmedj-2020-139531.
doi: 10.1136/postgradmedj-2020-139531.
https://pubmed.ncbi.nlm.nih.gov/33589490/

Leahey A.M. Let's Make Retinoblastoma a Zero-Death Cancer. Ophthalmology. Retina. 2020 Jun;4
doi: 10.1016/j.oret.2020.03.016.
https://pubmed.ncbi.nlm.nih.gov/32507277/

Leclerc R., Olin J. An Overview of Retinoblastoma and Enucleation in Pediatric Patients // AORN J. Wiley-Blackwell, 2020. Vol. 111, № 1. P. 69–79.
https://doi.org/10.1002/aorn.12896
https://aornjournal.onlinelibrary.wiley.com/doi/abs/10.1002/aorn.12896

Lee C., Kim J.K. Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications. Journal of cellular physiology. 2020 Aug 25.
doi: 10.1002/jcp.30022.
https://pubmed.ncbi.nlm.nih.gov/32840881/

Lee C., Kim J.K. Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications. Journal of cellular physiology. 2021 Apr;236(4):2318-2332.
doi: 10.1002/jcp.30022. Epub 2020 Aug 25.
https://pubmed.ncbi.nlm.nih.gov/32840881/

Lee J.S., Kim J.Y., Jung C., Woo S.J. Iatrogenic Ophthalmic Artery Occlusion and Retinal Artery Occlusion. // Progress in Retinal and Eye Research. 2020 Mar 9.
DOI: 10.1016/j.preteyeres.2020.100848
https://www.ncbi.nlm.nih.gov/pubmed/32165219

Lemaître S., Lévy-Gabriel C., Pacquement H., Cassoux N. Unilateral retinoblastoma with reactive orbital inflammation: A case report. Journal français d'ophtalmologie. 2020 Dec 11:S0181-5512(20)30556-8.
doi: 10.1016/j.jfo.2020.05.020.
https://pubmed.ncbi.nlm.nih.gov/33317854/

Leonini S., Bertelli E., Bracco S., Guasti A. Thoughts on "Estimation of radiation exposure of children undergoing superselective intra-arterial chemotherapy for retinoblastoma treatment: assessment of local diagnostic reference levels as a function of age, sex, and interventional success". Neuroradiology. 2020 Oct 19.
doi: 10.1007/s00234-020-02587-6.
https://pubmed.ncbi.nlm.nih.gov/33074360/

Liang T.Y., Zhu X.Y., Hua X.M., Ji X.D., Zhao P.Q. Combined intra-arterial chemotherapy and intravitreal melphalan for the treatment of advanced unilateral retinoblastoma. Int J Ophthalmol. 2020 Feb 18;13(2):257-262.
DOI: 10.18240/ijo.2020.02.09

Liao A., Hsieh T., Francis J.H., Lavery J.A., Mauguen A., Brodie S.E., Abramson D.H. Toxicity and efficacy of intravitreal Melphalan for retinoblastoma: 25 µg Versus 30 µg.
DOI:10.1097/IAE.0000000000002782

Li C., Zhao J., Sun W. microRNA-222-Mediated VHL Downregulation Facilitates Retinoblastoma Chemoresistance by Increasing HIF1α Expression. Investigative ophthalmology & visual science. 2020 Aug 3
doi: 10.1167/iovs.61.10.9.
https://pubmed.ncbi.nlm.nih.gov/32756923/

Li L., Xu B., Li C.R., Zhang M.M., Wu S.J., Dang W.J., Liu J.C., Sun S.G., Zhao W. Anti-proliferation and apoptosis-inducing effects of sodium aescinate on retinoblastoma Y79 cells. International journal of ophthalmology. 2020, Oct 18.
doi: 10.18240/ijo.2020.10.06.
https://pubmed.ncbi.nlm.nih.gov/33078103/

Li M., Yang J., Liu K., Yang J., Zhan X., Wang L., Shen X., Chen J., Mao Z. p16 promotes proliferation in cervical carcinoma cells through CDK6-HuR-IL1A axis. J Cancer. 2020 Jan 14;11(6):1457-1467.
DOI: 10.7150/jca.35479. eCollection 2020.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995400/

Lin F.Y., Chintagumpala M.M. Neonatal Retinoblastoma. Clinics in perinatology. 2021 Mar;48(1):53-70.
doi: 10.1016/j.clp.2020.12.001.
https://pubmed.ncbi.nlm.nih.gov/33583507/

Lin S.Y., Yen K.G., Zhu H., Moisiuc A., Chilakapati M. Abnormal Red Reflex: Etiologies in a Pediatric Ophthalmology Population. Clinical pediatrics. 2020 Jul
doi: 10.1177/0009922820916892.
https://pubmed.ncbi.nlm.nih.gov/32503396/

Liu B., Gao T., Wu H.Y., Wan M. Erb-B2 receptor tyrosine kinase 2 knockdown inhibits retinoblastoma progression via Wnt/beta-catenin signaling pathway in vitro. Journal of biological regulators and homeostatic agents. 2021 Jan 22;35(1).
doi: 10.23812/20-594-L.
https://pubmed.ncbi.nlm.nih.gov/33480220/

Liu C.C., Mohmood A., Hamzah N., Lau J.H., Khaliddin N., Rahmat J. Intra-arterial chemotherapy for retinoblastoma: Our first three-and-a-half years' experience in Malaysia. PloS one. 2020 May 1.
DOI: 10.1371/journal.pone.0232249
https://pubmed.ncbi.nlm.nih.gov/32357178/?from_term=retinoblastoma&from_sort=date&from_page=6&from_pos=1

Liu H., Hua Z. Q., Jin Z. B. Modeling human retinoblastoma using embryonic stem cell-derived retinal organoids. STAR protocols, 2(2), 100444.
doi: 10.1016/j.xpro.2021.100444
https://pubmed.ncbi.nlm.nih.gov/33899024

Liu H., Liu Y., Chen Y., Liu H. Detection of parotid metastasis from retinoblastoma by [18F]FDG PET/CT scan. Revista española de medicina nuclear e imagen molecular. 2021 Jul 31:S2253-654X(21)00028-7. English, Spanish. PMID: 34344630.
doi: 10.1016/j.remn.2021.02.003.
https://pubmed.ncbi.nlm.nih.gov/34344630/

Liu H., Zhang Y., Zhang Y.Y., Li Y.P., Hua Z.Q., Zhang C.J., Wu K.C., Yu F., Zhang Y., Su J., Jin Z.B. Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin. Proceedings of the National Academy of Sciences of the United States of America. 2020 Dec 29;117(52):33628-33638.
doi: 10.1073/pnas.2011780117.
https://pubmed.ncbi.nlm.nih.gov/33318192/

Liu X., He J., Mao L., Zhang Y., Cui W., Duan S., Jiang A., Gao Y., Sang Y., Huang G.
EPZ015666, a selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an antitumour effect in retinoblastoma. Experimental eye research. 2020 Oct 6.
doi: 10.1016/j.exer.2020.108286.
https://pubmed.ncbi.nlm.nih.gov/33035554/

Liu X., Li X., Li J. Long Non-coding RNA FEZF1-AS1 Promotes Growth and Reduces Apoptosis Through Regulation of miR-363-3p/PAX6 Axis in Retinoblastoma. Biochemical genetics. 2021 Jan 11.
doi: 10.1007/s10528-020-10026-7.
https://pubmed.ncbi.nlm.nih.gov/33432525/

Liu X.M., Li X.F., Li J.C. MiR-146a functions as a potential tumor suppressor in retinoblastoma by negatively regulate neuro-oncological ventral antigen-1. The Kaohsiung journal of medical sciences. 2020 Dec 19.
doi: 10.1002/kjm2.12337.
https://pubmed.ncbi.nlm.nih.gov/33340248/

Liu X.M., Li X.F., Li J.C. MiR-146a functions as a potential tumor suppressor in retinoblastoma by negatively regulate neuro-oncological ventral antigen-1.
The Kaohsiung journal of medical sciences. 2021 Apr;37(4):286-293.
doi: 10.1002/kjm2.12337.
https://pubmed.ncbi.nlm.nih.gov/33340248/

Liu Z., Huang Y., Zhang F., Tang H., Wang Y. Autophagy-related gene 7 deficiency caused by miR-154-5p overexpression suppresses the cell viability and tumorigenesis of retinoblastoma by increasing cell apoptosis. Annals of translational medicine. 2020 Nov;8(21):1451.
doi: 10.21037/atm-20-6009.
https://pubmed.ncbi.nlm.nih.gov/33313196/

Li X.H., Shi A.J., Li J., Yuan H.F. Plasma miR-6089 as potential diagnostic biomarker for retinoblastoma. International ophthalmology. 2021 Mar 27.
doi: 10.1007/s10792-021-01808-y.
https://pubmed.ncbi.nlm.nih.gov/33772700/

Li Z., Guo Z., Chu D., Feng H., Zhang J., Zhu L., Li J. Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles. Drug Deliv. 2020 Dec;27(1):358-366.
DOI: 10.1080/10717544.2020.1730522
https://www.tandfonline.com/…/full/10…/10717544.2020.1730522
https://pubmed.ncbi.nlm.nih.gov/32091275/

Lohmann D.R., Gallie B.L. Retinoblastoma. 2000 Jul 18 [updated 2018 Nov 21]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. PMID: 20301625.
https://pubmed.ncbi.nlm.nih.gov/20301625/

López J.P., Barriga M.M., Lecea D., Parada C., Stephens G. Ophthalmology examination during well-child visits in primary care health centres: Knowledge and difficulties experienced by health workers. Archivos de la Sociedad Española de Oftalmología. 2020 Oct 13
doi: 10.1016/j.oftal.2020.05.029.
https://pubmed.ncbi.nlm.nih.gov/33067032/
M

Ma H., Nie C., Chen Y., Li J., Xie Y., Tang Z., Gao Y., Ai S., Mao Y., Sun Q., Lu R.
Therapeutic targeting PLK1 by ON-01910.Na is effective in local treatment of retinoblastoma. Oncology research. 2021 Feb 11.
doi: 10.3727/096504021X16130322409507.
https://pubmed.ncbi.nlm.nih.gov/33573708/

Maloney S.M., Williams B.K. Jr., Shields C.L. Resolution of Nystagmus Following Treatment for Retinoblastoma. JAMA Ophthalmology. 2020 Apr 1
DOI: 10.1001/jamaophthalmol.2019.0382
https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2763886

Mao Y., Nie Q., Yang Y., Mao G. Identification of co‑expression modules and hub genes of retinoblastoma via co‑expression analysis and protein‑protein interaction networks. Molecular medicine reports. 2020 Aug
doi: 10.3892/mmr.2020.11189
https://pubmed.ncbi.nlm.nih.gov/32468072/

Martínez-Sánchez M., Hernandez-Monge J., Rangel M., Olivares-Illana V. Retinoblastoma: from discovery to clinical management. The FEBS journal. 27 May. 2021
doi:10.1111/febs.16035
https://pubmed.ncbi.nlm.nih.gov/34042282/

Martínez-Sánchez M., Moctezuma-Dávila M., Hernandez-Monge J., Rangel-Charqueño M., Olivares-Illana V. Analysis of the p53 pathway in peripheral blood of retinoblastoma patients; potential biomarkers. PloS one. Jun 5.
doi: 10.1371/journal.pone.0234337
https://pubmed.ncbi.nlm.nih.gov/32502182/

Mattosinho C., Moura A.T., Grigorovski N., Araújo L.H., Ferman S., Ribeiro K. Socioeconomic status and retinoblastoma survival: Experience of a tertiary cancer center in Brazil. Pediatric Blood and Cancer. 2020 Oct 22.
doi: 10.1002/pbc.28757.
https://pubmed.ncbi.nlm.nih.gov/33089657/

Ma X., Jin L., Lei X., Tong J., Wang R. MicroRNA‑363‑3p inhibits cell proliferation and induces apoptosis in retinoblastoma cells via the Akt/mTOR signaling pathway by targeting PIK3CA.Oncology reports. 2020 May.
DOI: 10.3892/or.2020.7544
https://pubmed.ncbi.nlm.nih.gov/32323827/?from_term=retinoblastoma&from_sort=date&from_page=7&from_pos=2

Meel R, Kashyap S, Bakhshi S, Singh Bajaj M, Wadhwani M. Retinoblastoma in Children Older than 6 Years of Age. Ocul Oncol Pathol. 2020 Dec;6(6):395-404.
doi: 10.1159/000509040
https://pubmed.ncbi.nlm.nih.gov/33447589/

Mehyar M., Mosallam M., Tbakhi A., Saab A., Sultan I., Deebajah R., Jaradat I., AlJabari R., Mohammad M., Al Nawaiseh I., Al-Hussaini M., Yousef Y.A. Impact of RB1 gene mutation type in retinoblastoma patients on clinical presentation and management outcome. // Hematology/Oncology and Stem Cell Therapy. 2020 Mar 23
DOI: 10.1016/j.hemonc.2020.02.006
https://pubmed.ncbi.nlm.nih.gov/32222358/?from_term=retinoblastoma&from_sort=date&from_pos=4

Meng N., Zhao Z., Shi C., Xia L. Inhibiting the Progression of Human Retinoblastoma Cell by Downregulation of MMP-2/MMP-9 Using Short Hairpin RNAs (shRNAs) In Vitro. Journal of ophthalmology. 2020 May 13.
doi: 10.1155/2020/4912347
https://pubmed.ncbi.nlm.nih.gov/32509341/

Meredith D.M., Charville G.W., Fletcher C.D.M., Hornick J.L. Distantly Metastatic Retinoblastoma to Soft Tissue and Bone: A Challenging Diagnosis Highlighting the Utility of CRX. The American journal of surgical pathology. 2020 Nov 5.
doi: 10.1097/PAS.0000000000001620
https://pubmed.ncbi.nlm.nih.gov/33165094/

Meredith D.M., Charville G.W., Fletcher C.D.M., Hornick J.L. Distantly Metastatic Retinoblastoma to Soft Tissue and Bone: A Challenging Diagnosis Highlighting the Utility of CRX. The American journal of surgical pathology. 2021 Jun 1;45(6):820-824.
doi: 10.1097/PAS.0000000000001620.
https://pubmed.ncbi.nlm.nih.gov/33165094/

Miracco C., Toti P., Gelmi M.C., Aversa S., Baldino G., Galluzzi P., De Francesco S., Petrelli F., Sorrentino E., Belmonte G., Galimberti D., Bracco S., Hadjistilianou T.
Retinoblastoma Is Characterized by a Cold, CD8+ Cell Poor, PD-L1- Microenvironment, Which Turns Into Hot, CD8+ Cell Rich, PD-L1+ After Chemotherapy. Investigative ophthalmology & visual science. 2021 Feb 1;62(2):6.
doi: 10.1167/iovs.62.2.6.
https://pubmed.ncbi.nlm.nih.gov/33538768/

Mirzayev I., Gündüz A.K., Biçer Ö., Tarlan B. The Final Diagnosis: Retinoblastoma or Pseudoretinoblastoma. Journal of pediatric ophthalmology and strabismus. May-Jun 2021;58(3):161-167.
doi:10.3928/01913913-20210108-01
https://pubmed.ncbi.nlm.nih.gov/34039153/

Mirzayev I., Gündüz A.K., Yavuz K., Şekkeli M.Z., Özalp Ateş F.S., Ünal E., Taçyıldız N. Secondary intra-arterial chemotherapy and/or intravitreal chemotherapy as salvage treatment for retinoblastoma.
European journal of ophthalmology. 2020 Sep 22
doi: 10.1177/1120672120957587.
https://pubmed.ncbi.nlm.nih.gov/32962409/

Mndeme F.G., Mmbaga B.T, Kim M.J., Sinke L., Allen L., Mgaya E., Bastawrous A., MacLeod D., Burton M.J., Gilbert C., Bowman R. Red reflex examination in reproductive and child health clinics for early detection of paediatric cataract and ocular media disorders: cross-sectional diagnostic accuracy and feasibility studies from Kilimanjaro, Tanzania. Eye. 2020 Jun 16
doi: 10.1038/s41433-020-1019-5.
https://pubmed.ncbi.nlm.nih.gov/32546747/

Mohanan A., Meel R., Venkatesh P., Kashyap S. Retinal tumour outcome with IVC in retinoblastoma. Eye. 2020 Jul 14
doi: 10.1038/s41433-020-1076-9
https://pubmed.ncbi.nlm.nih.gov/32665672/

Mokánszki A., Chang Chien Y.C., Mótyán J.A., Juhász P., Bádon E.S., Madar L., Szegedi I., Kiss C., Méhes G. Novel RB1 and MET Gene Mutations in a Case with Bilateral Retinoblastoma Followed by Multiple Metastatic Osteosarcoma.
Diagnostics. 2020 Dec 25;11(1):E28.
doi: 10.3390/diagnostics11010028.
https://pubmed.ncbi.nlm.nih.gov/33375764/

Monroe E.J., Chick J.F.B., Stacey A.W., Millard N.E., Geyer J.R., Ramoso L.R., Ghodke B.V., Hallam D.K. Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: a retrospective analysis of 96 consecutive pediatric interventions using five distinct protocols.Pediatric radiology. 2020 Nov 24.
doi: 10.1007/s00247-020-04892-x
https://pubmed.ncbi.nlm.nih.gov/33231717/

Monroe E.J., Chick J.F.B., Stacey A.W., Millard N.E., Geyer J.R., Ramoso L.R., Ghodke B.V., Hallam D.K. Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: a retrospective analysis of 96 consecutive pediatric interventions using five distinct protocols. Pediatric radiology. 2021 Apr;51(4):649-657.
doi: 10.1007/s00247-020-04892-x.
https://pubmed.ncbi.nlm.nih.gov/33231717

Moradi S., Mokhtari-Dizaji M., Ghassemi F., Sheibani S., Asadi Amoli F. Increasing the efficiency of the retinoblastoma brachytherapy protocol with ultrasonic hyperthermia and gold nanoparticles: A rabbit model. International journal of radiation biology. 2020 Oct 19:1-34.
doi: 10.1080/09553002.2020.1838657.
https://pubmed.ncbi.nlm.nih.gov/33074061/

Moradi S., Mokhtari-Dizaji M., Ghassemi F., Sheibani S., Asadi Amoli F. Increasing the efficiency of the retinoblastoma brachytherapy protocol with ultrasonic hyperthermia and gold nanoparticles: a rabbit model. International journal of radiation biology. 2020 Nov 9:1-14.
doi: 10.1080/09553002.2020.1838657.
https://pubmed.ncbi.nlm.nih.gov/33074061/

Moses C., Flegg K., Dimaras H. Patient knowledge, experiences and preferences regarding retinoblastoma and research: A qualitative study.
https://doi.org/10.1111/hex.13043
https://onlinelibrary.wiley.com/doi/full/10.1111/hex.13043

Mostaghimi H., Ahmadabad F.G., Rezaei H. Super-selective intra-arterial platinum-based chemotherapy concurrent with low-dose-rate plaque brachytherapy in the treatment of retinoblastoma: A simulation study. Journal of cancer research and therapeutics. 2021 Jan-Mar;17(1):130-135.
doi: 10.4103/jcrt.JCRT_340_19.
https://pubmed.ncbi.nlm.nih.gov/33723143/

Mouawad R., Himadewi P., Kadiyala D., Arnosti D.N. Selective repression of the Drosophila cyclin B promoter by retinoblastoma and E2F proteins.Biochimica et Biophysica Acta - Gene Regulatory Mechanisms. 2020 Apr 7
DOI: 10.1016/j.bbagrm.2020.194549
https://pubmed.ncbi.nlm.nih.gov/32275964/?from_term=retinoblastoma&from_sort=date&from_pos=8

Moulay Lakhdar I., Ferlazzo M.L., Al Choboq J., Berthel E., Sonzogni L., Devic C., Granzotto A., Thariat J., Foray N. Fibroblasts from Retinoblastoma Patients Show Radiosensitivity Linked to Abnormal Localization of the ATM Protein. Current eye research. 2020 Aug 30
doi: 10.1080/02713683.2020.1808998.
https://pubmed.ncbi.nlm.nih.gov/32862699/

Moulin A.P., Stathopoulos C., Marcelli F., Schoumans Pouw J., Beck-Popovic M., Munier F.L. Secondary enucleated retinoblastoma with MYCN amplification. Ophthalmic Genetics. 2021 Apr 19:1-6.
doi: 10.1080/13816810.2021.1897847.
https://pubmed.ncbi.nlm.nih.gov/33870828/

Munier F.L., Beck-Popovic M., Chantada G.L., Cobrinik D., Kivelä T.T., Lohmann D., Maeder P., Moll A.C., Carcaboso A.M., Moulin A., Schaiquevich P., Bergin C., Dyson P.J., Houghton S., Puccinelli F., Vial Y., Gaillard M.C., Stathopoulos C. Corrigendum to "Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. "Alive, with good vision and no comorbidity"" [Prog. Retina Eye Res. 73 (2019) 100764] Progress in Retinal and Eye Research.. 2020 Apr 8
DOI: 10.1016/j.preteyeres.2020.100857
https://pubmed.ncbi.nlm.nih.gov/32278633/?from_term=retinoblastoma&from_sort=date&from_pos=3

Mu Y.T., Feng H.H., Yu J.Q., Liu Z.K., Wang Y., Shao J., Li R.H., Li D.K. Correction to: Curcumin suppressed proliferation and migration of human retinoblastoma cells through modulating NF-κB pathway. International ophthalmology. 2021 Jun;41(6):2301.
doi: 10.1007/s10792-020-01675-z.
https://pubmed.ncbi.nlm.nih.gov/33945061/

Mu Y.T., Feng H.H., Yu J.Q., Liu Z.K., Wang Y., Shao J., Li R.H., Li D.K. Curcumin suppressed proliferation and migration of human retinoblastoma cells through modulating NF-κB pathway. International ophthalmology. 2020 May 12.
DOI: 10.1007/s10792-020-01406-4
https://pubmed.ncbi.nlm.nih.gov/32399774/?from_term=retinoblastoma&from_sort=date&from_page=4&from_pos=2
N

Nadelmann J., Francis J.H., Brodie S.E., Muca E., Abramson D.H. Is intravitreal topotecan toxic to retinal function? The British journal of ophthalmology. 2020 Jul 14
doi: 10.1136/bjophthalmol-2020-316588.
https://pubmed.ncbi.nlm.nih.gov/32665221/

Narang S., Sindhu M., Jinagal J., Handa U., Kochhar S. Unusual presentation of Retinoblastoma. European journal of ophthalmology. 2020 Jul 2
doi: 10.1177/1120672120939388.
https://pubmed.ncbi.nlm.nih.gov/32613860/

Naser A.Y., Alrawashdeh H.M., Alwafi H., Alyami H.S., Dahmash E.Z., Ghoul I., Shishtawi A.A., Abdelwahab G.M., Qadus S., Taybeh E., Abuthawabeh R., Hassanin F., Alhartani Y.J., Alyami M.H., Salawati E.M., Alwan S.S. Knowledge and awareness of the general population and healthcare providers about retinoblastoma: it is time to know the glow. International journal of clinical practice. 2021 Apr 30:e14298.
doi: 10.1111/ijcp.14298.
https://pubmed.ncbi.nlm.nih.gov/33928718/

Nazha B., Inal C., Owonikoko T.K. Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy. Frontiers in oncology. 2020 Jul 7
doi: 10.3389/fonc.2020.01000.
https://pubmed.ncbi.nlm.nih.gov/32733795/

Nguyen M., Saunders J., Pacheco M.C., Stacey A.W. Progressive Preretinal Fibrosis with Late, Ossifying, Proliferative Retinopathy following Treatment for Retinoblastoma. Ocular oncology and pathology. 2021 Mar;7(1):44-47.
doi: 10.1159/000509809. Epub 2020 Sep 25.
https://pubmed.ncbi.nlm.nih.gov/33796516/

Ni H., Chai P., Yu J., Xing Y., Wang S., Fan J., Ge S., Wang Y., Jia R., Fan X. LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter. Cell death & disease. 2020 May 4.
DOI: 10.1038/s41419-020-2524-y
https://pubmed.ncbi.nlm.nih.gov/32366932/?from_term=retinoblastoma&from_sort=date&from_page=5&from_pos=7

Nie C., Ma H., Gao Y., Li J., Tang Z., Chen Y., Lu R. RNA Sequencing and Bioinformatic Analysis on Retinoblastoma Revealing Cell Cycle Deregulation being a Key Process in Retinoblastoma Tumorigenesis. // Acta Ophthalmologica. 2020 Mar 6.
DOI: 10.1159/000506993
https://www.ncbi.nlm.nih.gov/pubmed/32146475

Norrie J.L., Nityanandam A., Lai K., Chen X., Wilson M., Stewart E., Griffiths L., Jin H., Wu G., Orr B., Tran Q., Allen S., Reilly C., Zhou X., Zhang J., Newman K., Johnson D., Brennan R., Dyer M.A. Retinoblastoma from human stem cell-derived retinal organoids. Nature communications. 2021 Jul 27;12(1):4535. PMID: 34315877; PMCID: PMC8316454.
doi: 10.1038/s41467-021-24781-7.
https://pubmed.ncbi.nlm.nih.gov/34315877/

Nummi K., Kivelä T. Retinoblastoma in Finland, 1964-2014: incidence and survival. // British Journal of Ophthalmology. 2020 Mar 25
DOI: 10.1136/bjophthalmol-2019-315744.
https://pubmed.ncbi.nlm.nih.gov/32217545/?from_term=retinoblastoma&from_sort=date&from_pos=9

Nummi K., Kivelä T.T. Retinoblastoma in Finland, 1964-2014: incidence and survival. Br J Ophthalmol. 2021 Jan;105(1):63-69.
doi: 10.1136/bjophthalmol-2019-315744.
https://pubmed.ncbi.nlm.nih.gov/32217545/
O

Oatess T.L., Chen P.H., Daniels A.B., Himmel L.E. Severe Periocular Edema after Intraarterial Carboplatin Chemotherapy for Retinoblastoma in a Rabbit (Oryctolagus cuniculus) Model. // Comparative Medicine. 2020 Mar 11.
DOI: 10.30802/AALAS-CM-18-000146
https://www.ncbi.nlm.nih.gov/pubmed/32160941

Ohan H., Minassian G., Minassian H., Farooq T., Zdilla M.J. Retinoblastoma in Infancy with Subsequent Bladder Leiomyosarcoma in Adulthood: Genomic Considerations.Urology. 2020 Mar 19
DOI: 10.1016/j.urology.2020.03.010
https://pubmed.ncbi.nlm.nih.gov/32197986/?from_term=retinoblastoma&from_sort=pubdate&from_size=50&from_pos=33

Ophthalmic surgery, lasers & imaging retina. 2020 Dec 1;51(12):732.
doi: 10.3928/23258160-20201202-09.
https://pubmed.ncbi.nlm.nih.gov/33339056/

Opitz M., Bos D., Deuschl C., Radbruch A., Zensen S., Sirin S., Forsting M., Bechrakis N., Biewald E., Bornfeld N., Ketteler P., Timmermann B., Stuschke M., Guberina M., Wetter A., Göricke S., Guberina N. Estimation of radiation exposure of children undergoing superselective intra-arterial chemotherapy for retinoblastoma treatment: assessment of local diagnostic reference levels as a function of age, sex, and interventional success. Neuroradiology. 2020 Aug 29.
doi: 10.1007/s00234-020-02540-7.
https://pubmed.ncbi.nlm.nih.gov/32862237/

Opitz M., Wetter A., Guberina N. Thoughts on "Estimation of radiation exposure of children undergoing superselective, intra-arterial chemotherapy for retinoblastoma treatment: Assessment of Local Diagnostic Reference Levels as a function of age, sex and interventional success". Neuroradiology. 2020 Nov 3.
doi: 10.1007/s00234-020-02594-7.
https://pubmed.ncbi.nlm.nih.gov/33141236/

Oporto J.I., Zúñiga P., Ossandón D., Zanolli M., Pérez V., López J.P., Stetcher X., Rodríguez A., Puentes Á., Rustom S., Lobos J. Intra-arterial chemotherapy for retinoblastoma treatment in Chile: experience and results 2013-2020.
Archivos de la Sociedad Española de Oftalmología. 2020 Dec 2:S0365-6691(20)30391-9.
doi: 10.1016/j.oftal.2020.10.002.
https://pubmed.ncbi.nlm.nih.gov/33279354/

Oporto J.I., Zúñiga P., Ossandón D., Zanolli M., Pérez V., López J.P., Stetcher X., Rodríguez A., Puentes Á., Rustom S., Lobos J. Intra-arterial chemotherapy for retinoblastoma treatment in Chile: Experience and results 2013-2020. Archivos de la Sociedad Española de Oftalmología. 2021 Jun;96(6):288-292.
doi: 10.1016/j.oftale.2020.10.003.
https://pubmed.ncbi.nlm.nih.gov/34092282/

Oronowicz J., Reinhard J., Reinach P.S., Ludwiczak S., Luo H., Omar Ba Salem M.H., Kraemer M.M., Biebermann H., Kakkassery V., Mergler S. Ascorbate-induced oxidative stress mediates TRP channel activation and cytotoxicity in human etoposide-sensitive and -resistant retinoblastoma cells. Laboratory investigation; a journal of technical methods and pathology. 2020 Sep 18.
doi: 10.1038/s41374-020-00485-2.
https://pubmed.ncbi.nlm.nih.gov/32948812/

Orjuela-Grimm M., Carreño S.B., Liu X., Ruiz A., Medina P., Ramirez Ortiz M.A., Rendon J.R., Molina N.C.L., Pinilla H., Hinojosa D., Rodriguez L., Connor A.O., Rodriguez F.M., Castañeda M.V.P., Cabrera-Muñoz L. Sunlight exposure in infancy decreases risk of sporadic retinoblastoma, extent of intraocular disease.
Cancer Reports. 2021 May 7:e1409.
doi: 10.1002/cnr2.1409.
https://pubmed.ncbi.nlm.nih.gov/33960746/

Outtaleb F.Z., Kora L., Jabrane G., Serbati N., El Maaloum L., Allali B., El Kettani A., Dehbi H. 13q interstitial deletion in a moroccan child with hereditary retinoblastoma and intellectual disability: A case report. Annals of medicine and surgery. 2020 Nov 7;60:334-337.
doi: 10.1016/j.amsu.2020.10.063.
https://pubmed.ncbi.nlm.nih.gov/33224486/

Özdemir Özdoğan G., Kaya H. Next-Generation Sequencing Data Analysis on Pool-Seq and Low-Coverage Retinoblastoma Data. Interdisciplinary sciences, computational life sciences. 2020 Jun 9.
doi: 10.1007/s12539-020-00374-8.
https://pubmed.ncbi.nlm.nih.gov/32519123/

P

Pacheco R.R., Vaidya S., Shields C.L. Benefit of Patching Therapy to Minimize Amblyopia After Retinoblastoma Treatment. Ophthalmology. Retina. 2020 Jun;4.
doi: 10.1016/j.oret.2020.01.013.
https://pubmed.ncbi.nlm.nih.gov/32507274/

Panthagani J., Montecinos P., López J.P., Parulekar M. Cystoid macular edema following intravitreal chemotherapy treatment for retinoblastoma. Pediatric blood & cancer. 2020 Jul 7.
doi: 10.1002/pbc.28348
https://pubmed.ncbi.nlm.nih.gov/32634267/

Passos Gibson V., Mouna Derbali R., Trong Phan H., Tahiri H., Allen C., Hardy P., Leblond Chain J. Survivin silencing improved the cytotoxicity of carboplatin and melphalan in Y79 and primary retinoblastoma cells. International journal of pharmaceutics. 2020 Aug 27
doi: 10.1016/j.ijpharm.2020.119824.
https://pubmed.ncbi.nlm.nih.gov/32861768/

Patel J.M., Goss A., Garber J.E., Torous V., Richardson E.T., Haviland M.J., Hacker M.R., Freeman G.J., Nalven T., Alexander B., Lee L., Collins L.C., Schnitt S.J., Tung N. Retinoblastoma protein expression and its predictors in triple-negative breast cancer. NPJ breast cancer. 2020 Jun 5.
doi: 10.1038/s41523-020-0160-4
https://pubmed.ncbi.nlm.nih.gov/32550264/

Patel S., Vogel J., Bradley K., Chuba P.J., Buchsbaum J., Krasin M.J. Rare tumors: Retinoblastoma, nasopharyngeal cancer, and adrenocorticoid tumors. Pediatric blood & cancer. 2021 May;68 Suppl 2:e28253.
doi: 10.1002/pbc.28253.
https://pubmed.ncbi.nlm.nih.gov/33818883/

PDQ Pediatric Treatment Editorial Board. Retinoblastoma Treatment (PDQ®): Patient Version. 2021 Mar 22. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–.
https://pubmed.ncbi.nlm.nih.gov/26389197/

Peck T., Gervasio K.A., Zhang P.JL., Shields C.L., Lally S.E., Eagle R.C. Jr, Milman T. Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma with Myxoid Stroma in a Hereditary Retinoblastoma Survivor. Ocular Oncology and Pathology. 2020 Mar 6 DOI: 10.1159/000501523. https://pubmed.ncbi.nlm.nih.gov/32258014/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=5

Persaud Y., Seddiq M., Wu Y.M., Robinson D.R., Poulik J., Altinok D., Roarty J.D., Mody R., Taub J.W. Unusual clinical behavior of a very late retinoblastoma relapse in a patient with a germline RB mutation. Pediatric blood & cancer. 2021 May 18:e29064.
doi: 10.1002/pbc.29064.
https://pubmed.ncbi.nlm.nih.gov/34003562/

PLOS ONE Editors. Expression of Concern: RNAi Mediated Tiam1 Gene Knockdown Inhibits Invasion of Retinoblastoma. PLoS One. 2021 May 26;16(5):e0252495.
doi: 10.1371/journal.pone.0252495.
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0252495

Polski A., Xu L., Prabakar R.K., Kim J.W., Shah R., Jubran R., Kuhn P., Cobrinik D., Hicks J., Berry J.L. Cell-Free DNA Tumor Fraction in the Aqueous Humor Is Associated With Therapeutic Response in Retinoblastoma Patients. Translational vision science & technology. 2020 Sep 30
doi: 10.1167/tvst.9.10.30.
https://pubmed.ncbi.nlm.nih.gov/33062393/

Polski A., Xu L., Prabakar R.K., Gai X., Kim J.W., Shah R., Jubran R., Kuhn P., Cobrinik D., Hicks J., Berry J.L. Variability in retinoblastoma genome stability is driven by age and not heritability. Genes, chromosomes & cancer. 2020 May 11.
DOI: 10.1002/gcc.22859
https://pubmed.ncbi.nlm.nih.gov/32390242/?from_term=retinoblastoma&from_sort=date&from_page=4&from_pos=7

Prajantawanich K., Sanpakit K., Narkbunnam N., Vathana N., Takpradit C., Phuakpet K., Pongtanakul B., Atchaneeyasakul L.O., Sinlapamongkolkul P., Buaboonnam J. Clinical Outcomes and Prognostic Factors of Thai Retinoblastoma Patients. Pediatrics international : official journal of the Japan Pediatric Society. 2020 Oct 6.
doi: 10.1111/ped.14498.
https://pubmed.ncbi.nlm.nih.gov/33022851/

Price E.A., Patel R., Scheimberg I., Kotiloglu Karaa E., Sagoo M.S,, Reddy M.A., Onadim Z. MYCN amplification levels in primary retinoblastoma tumors analyzed by Multiple Ligation-dependent Probe Amplification. Ophthalmic genetics. 2021 May 18:1-8.
doi: 10.1080/13816810.2021.1923038.
https://pubmed.ncbi.nlm.nih.gov/34003079/

R

Raguraman R., Parameswaran S., Kanwar J.R., Vasudevan M., Chitipothu S., Kanwar R.K., Krishnakumar S. Gene expression profiling of tumor stroma interactions in retinoblastoma. Experimental eye research. 2020 June 22.
doi: 10.1016/j.exer.2020.108067
https://pubmed.ncbi.nlm.nih.gov/32585195/

Raizis A.M., Racher H.M., Foucal A., Dimaras H., Gallie B.L., George P.M.
DNA hypermethylation/boundary control loss identified in retinoblastomas associated with genetic and epigenetic inactivation of the RB1 gene promoter.
Epigenetics. 2020 Dec 1:1-15.
doi: 10.1080/15592294.2020.1834911.
https://pubmed.ncbi.nlm.nih.gov/33258708/

Rajeshuni N., Whittemore A.S., Ludwig C.A., Mruthyunjaya P., Moshfeghi D.M. Reply to Comment on: Racial, Ethnic, and Socioeconomic Disparities in Retinoblastoma Enucleation: A Population-Based Study, SEER 18 2000-2014. American journal of ophthalmology. 2020 Jul 10.
doi: 10.1016/j.ajo.2020.04.038.
https://pubmed.ncbi.nlm.nih.gov/32660706/

Rakhshan R., Atashi H.A., Hoseinian M., Jafari A., Haghighi A., Ziyadloo F., Razizadeh N., Ghasemian H., Nia M.M.K., Sefidi A.B., Arani H.Z. The Synergistic Cytotoxic and Apoptotic Effect of Resveratrol and Naringenin on Y79 Retinoblastoma Cell Line. Anti-cancer agents in medicinal chemistry. 2021 Jan 12.
doi: 10.2174/1871520621666210112121051.
https://pubmed.ncbi.nlm.nih.gov/33438556/

Rastogi N., Kapoor R., Yadav S.P. Haploidentical Hematopoietic Stem Cell Transplantation for Relapsed Metastatic Retinoblastoma. Journal of pediatric hematology/oncology. 2020 Nov;42(8):499.
doi: 10.1097/MPH.0000000000001955.
https://pubmed.ncbi.nlm.nih.gov/33003140/

Ratna H. Heritable Retinoblastoma and Risk of Developing Second Primary Cancer. JAMA Network Open. 2020 Oct 1.
doi: 10.1001/jamanetworkopen.2020.22569.
https://pubmed.ncbi.nlm.nih.gov/33090221/

Raval V., Bowen R.C., Soto H., Singh A. Chemotherapy for Retinoblastoma: Impact of Intravitreal Chemotherapy. Asia-Pacific journal of ophthalmology. 2020 Sep 9.
doi: 10.1097/APO.0000000000000322.
https://pubmed.ncbi.nlm.nih.gov/32925294/

Raval V., DeBenedictis M., Bowen R., Soto H., Davanzo J., Singh A. Retinoblastoma in twins: Risk assessment of genotypic variants. Indian journal of ophthalmology. 2021 May;69(5):1230-1233.
doi: 10.4103/ijo.IJO_2811_20.
https://pubmed.ncbi.nlm.nih.gov/33913866/

Ravishankar H., Mangani A.S., Phoebe Moses G.L., Mani S.P., Parameswaran S., Khetan V., Ganesan S., Krishnakumar S. Serum exosomal miRNA as biomarkers for Retinoblastoma.
Experimental eye research.. 2020 Aug 11
doi: 10.1016/j.exer.2020.108184.
https://pubmed.ncbi.nlm.nih.gov/32795526/

Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma
DOI:https://doi.org/10.1016/j.ophtha.2020.05.024

Reddy M.A., Butt M., Hinds A.M., Duncan C., Price E.A., Sagoo M.S., Onadim Z. Prognostic information for known genetic carriers of RB1 pathogenic variants (germline and mosaic).
Ophthalmology. Retina. 2020 Aug 21
doi: 10.1016/j.oret.2020.08.010.
https://pubmed.ncbi.nlm.nih.gov/32835838/

Reinhard J., Wagner N., Krämer M.M., Jarocki M., Joachim S.C., Dick H.B., Faissner A., Kakkassery V. Expression Changes and Impact of the Extracellular Matrix on Etoposide Resistant Human Retinoblastoma Cell Lines. International journal of molecular sciences. 2020 Jun 17.
doi: 10.3390/ijms21124322.
https://pubmed.ncbi.nlm.nih.gov/32560557/

Reynolds M., Lueder G., Gordon M., Hayashi R.J. Developmental Delay and School Performance Among Retinoblastoma Survivors: Development/school morbidity among retinoblastoma survivors. American journal of ophthalmology. 2021 May 6:S0002-9394(21)00224-5.
doi: 10.1016/j.ajo.2021.04.025.
https://pubmed.ncbi.nlm.nih.gov/33965417/

Reynolds M.M., Sein J., Hayashi R., Lueder G. Treatment of small and medium retinoblastoma tumors with Iris diode laser. European journal of ophthalmology. 2021 Feb 2:1120672121991390.
doi: 10.1177/1120672121991390.
https://pubmed.ncbi.nlm.nih.gov/33530736/

Riazi-Esfahani H., Masoomian B., Ghassemi F. Intra-Arterial Chemotherapy: New Hope for Adult Retinoblastoma Treatment-A Case Report and Brief Review. Case reports in ophthalmological medicine. 2021 Jul 9;2021:6639900. PMID: 34336323; PMCID: PMC8289600.
doi: 10.1155/2021/6639900.
https://pubmed.ncbi.nlm.nih.gov/34336323/

Rishi P. Commentary: Current standards in retinoblastoma care. Indian journal of ophthalmology. 2020 Nov;68(11):2367.
doi: 10.4103/ijo.IJO_3198_20.
https://pubmed.ncbi.nlm.nih.gov/33120618/

Roufayel R., Mezher R., Storey K.B. The Role of Retinoblastoma Protein in Cell Cycle Regulation: An Updated Review. Current molecular medicine. 2021 Jan 3.
doi: 10.2174/1566524020666210104113003.
https://pubmed.ncbi.nlm.nih.gov/33397238/

Ruben M., Yaghy A., Shields C.L. Retinoblastoma Vitreous Seeds Captured on OCT. Ophthalmology. Retina. 2020 Nov;4(11):1117.
doi: 10.1016/j.oret.2020.05.004.
https://pubmed.ncbi.nlm.nih.gov/33131675/

Runnels J., Acosta G., Rose A., Haynes M., Nikolaidis D., Wong A., Fiani B. The role for intra-arterial chemotherapy for refractory retinoblastoma: a systematic review. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2021 Apr 7.
doi: 10.1007/s12094-021-02610-z.
https://pubmed.ncbi.nlm.nih.gov/33826082/

Russo I., Levy-Gabriel C., Dupont A., Lumbroso-Le Rouic L., Cassoux N., Desjardins L., Bertozzi A.I., Coze C., Doz F., Savignoni A., Aerts I. Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome. Pediatric blood & cancer. 2020 Oct 24
doi: 10.1002/pbc.28721.
https://pubmed.ncbi.nlm.nih.gov/33098751/
S

Saal-Zapata G., Rodríguez R., Rodriguez-Calienes A., Cordero R. Contralateral catheterization of the ophthalmic artery to deliver intra-arterial chemotherapy in retinoblastoma. The neuroradiology journal. 2021 Jun 13:19714009211024632.
doi: 10.1177/19714009211024632.
https://pubmed.ncbi.nlm.nih.gov/34121503/

Saengwimol D., Chittavanich P., Laosillapacharoen N., Srimongkol A., Chaitankar V., Rojanaporn D., Aroonroch R., Suktitipat B., Saisawang C., Svasti S., Hongeng S., Kaewkhaw R. Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation.
Investigative ophthalmology & visual science. 2020 Dec 1;61(14):8.
doi: 10.1167/iovs.61.14.8.
https://pubmed.ncbi.nlm.nih.gov/33270844/

Saluja G., Lomi N., Kashyap S. Unilateral retinal dysplasia simulating retinoblastoma. BMJ case reports. 2020 Sep 16;
doi: 10.1136/bcr-2020-238463.
https://pubmed.ncbi.nlm.nih.gov/32938657/

Salviat F., Gauthier-Villars M., Carton M., Cassoux N., Lumbroso-Le Rouic L., Dehainault C., Levy C., Golmard L., Aerts I., Doz F., Bonnet-Serrano F., Hayek S., Savignoni A., Stoppa-Lyonnet D., Houdayer C. Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma. JAMA ophthalmology. 2020 Jun 18
doi: 10.1001/jamaophthalmol.2020.2100.
https://pubmed.ncbi.nlm.nih.gov/32556071/

Samuel J., Singh N., Kanwar J.R., Krishnakumar S., Kanwar R.K..
Corrigendum to Upregulation of sodium iodide symporter (NIS) protein expression by an innate immunity component: Promising potential for targeting radiosensitive retinoblastoma [Exp. Eye Res. 139 (2015) 108e114]. Experimental eye research. 2020 Aug 11
doi: 10.1016/j.exer.2020.108145.
https://pubmed.ncbi.nlm.nih.gov/32797940/

Santapuram P.R., Schremp E.A., Friedman D.L., Koyama T., Froehler M.T., Daniels A.B. Adverse Events, Burden and Outcomes of IV vs. Intra-arterial Chemotherapy for RB. Ophthalmology Retina. 2020 Sep 10
doi: 10.1016/j.oret.2020.09.006.
https://pubmed.ncbi.nlm.nih.gov/32920208/

Sarver A.L., Xie C., Riddle M.J., Forster C.L., Wang X., Lu H., Wagner W., Tolar J., Hallstrom T.C. Retinoblastoma tumor cell proliferation is negatively associated with an immune gene expression signature and increased immune cells.
Laboratory investigation; a journal of technical methods and pathology. 2021 Mar 3.
doi: 10.1038/s41374-021-00573-x.
https://pubmed.ncbi.nlm.nih.gov/33658609/

Schieffer K.M., Feldman A.Z., Kautto E.A., McGrath S., Miller A.R., Hernandez-Gonzalez M.E., LaHaye S., Miller K.E., Koboldt D.C., Brennan P., Kelly B., Wetzel A., Agarwal V., Shatara M., Conley S., Rodriguez D.P., Abu-Arja R., Shaikhkhalil A., Snuderl M., Orr B.A., Finlay J.L., Osorio D.S., Drapeau A.I., Leonard J.R., Pierson C.R., White P., Magrini V., Mardis E.R., Wilson R.K., Cottrell C.E., Boué D.R..
Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma.
Acta neuropathologica communications. 2021 Apr 7;9(1):61.
doi: 10.1186/s40478-021-01164-z.
https://pubmed.ncbi.nlm.nih.gov/33827698/

Schofield D., Zeppel M.J.B, Staffieri S., Shrestha R.N., Jelovic D., Lee E., Jamieson R.V. Preimplantation genetic diagnosis for retinoblastoma survivors: a cost-effectiveness study. Reproductive biomedicine & society online. 2020 May 11.
doi: 10.1016/j.rbms.2020.03.001.
https://pubmed.ncbi.nlm.nih.gov/32577540/

Schonfeld S.J, Kleinerman R.A., Abramson D.H., Seddon J.M., Tucker M.A., Morton L.M. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors.
British journal of cancer. 2021 Jan 21.
doi: 10.1038/s41416-020-01248-y.
https://pubmed.ncbi.nlm.nih.gov/33473166/

Selvarajah A., Flegg K., Sim W., Hu J.B., Gallie B.L., Shaikh F., Soliman S.E., Dimaras H. Clinical audit of retinoblastoma management: a retrospective single-institution study. Canadian journal of ophthalmology. 2021 May 30:S0008-4182(21)00163-0.
doi: 10.1016/j.jcjo.2021.04.019.
https://pubmed.ncbi.nlm.nih.gov/34077747/

Selvin S.S.T., Kuriakose T. An uncommon presentation of a refractory case of retinoblastoma. Orbit. 2020 Sep 2
doi: 10.1080/01676830.2020.1817950.
https://pubmed.ncbi.nlm.nih.gov/32873110/

Sepúlveda-Sánchez J.M., Gil-Gil M., Alonso-García M., Vaz Salgado M.Á., Vicente E., Mesía Barroso C., Rodríguez Sánchez Á., Durán G., De Las Peñas R., Muñoz-Langa J., Velasco G., Hernández-Laín A., Hilario A., Navarro Martín M., Benavides M., Oleaga L., Cantero Montenegro D., Ruano Y., Sánchez-Gómez P., Martín-Soberón M.C., Morales-Llombart R., Pachón V., Pineda E. Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO). Targeted oncology. 2020 Oct;15(5):613-622. doi: 10.1007/s11523-020-00754-6.
https://pubmed.ncbi.nlm.nih.gov/33025213/

Shakeel O., Pace N., Chambers T.M., Scheurer M.E., Ganguly A.A., Lupo P.J., Bunin G.R. Medical radiation exposure and risk of sporadic retinoblastoma.
Pediatric blood & cancer. 2020 Aug 2
doi: 10.1002/pbc.28633.
https://pubmed.ncbi.nlm.nih.gov/32743912/

Shanmugam P.M. Commentary: Retinoblastoma management-Where are we and where do we go from here? Indian journal of ophthalmology. 2020 Nov;68(11):2365-2366.
doi: 10.4103/ijo.IJO_1954_20.
https://pubmed.ncbi.nlm.nih.gov/33120618/

Shanthini T., Balaji S., Kim U., Muthukkaruppan V., Vanniarajan A. Genetic characterization of a patient with an unusual presentation of Waardenburg syndrome Type 4 and retinoblastoma. Pediatric blood & cancer. 2020 Jul 16
doi: 10.1002/pbc.28553.
https://pubmed.ncbi.nlm.nih.gov/32672397/

Sheehan A.P. Retinoblastoma: Early Diagnosis is Crucial. Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners. 2020 Aug 24
doi: 10.1016/j.pedhc.2020.06.006.
https://pubmed.ncbi.nlm.nih.gov/32855014/

Shields C.L., Bas Z., Tadepalli S., Dalvin L.A., Rao R., Schwendeman R., Lally S.E., Shields J.A., Shah A., Leahey A. Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre. Br J Ophthalmol. 2020 Feb 12.
DOI: 10.1136/bjophthalmol-2019-315572
Singh N., DeBenedictis M.J., Singh A.D. An Online Application for Retinoblastoma Surveillance. Ocular oncology and pathology. 2020 Oct; 6.
doi: 10.1159/000505751
https://pubmed.ncbi.nlm.nih.gov/33123532/

Shields C.L., Dockery P.W., Yaghy A., Duffner E.R., Levin H.J., Taylor O.S., Sajjadi Z., Lally S.E., Shields J.A., Rosenwasser R., Tjoumakaris S., Jabbour P. Intra-arterial chemotherapy for retinoblastoma in 341 consecutive eyes (1,292 infusions): comparative analysis of outcomes based on patient age, race, and sex. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, S1091-8531(21)00112-9. 24 May. 2021. doi:10.1016/j.jaapos.2020.12.006
https://pubmed.ncbi.nlm.nih.gov/34044113/

Shields C.L., Dockery P., Ruben M., Yaghy A., Sunday M.A., Duffner E.R., Levin H.J., Taylor O.S., Calotti M., Lally S.E., Shields J.A. Likelihood of Germline Mutation With Solitary Unilateral Retinoblastoma Based on Patient Age at Presentation: Analysis of 482 Consecutive Patients. Journal of pediatric ophthalmology and strabismus. 2021 Jun 1:1-10.
doi: 10.3928/01913913-20210414-02.
https://pubmed.ncbi.nlm.nih.gov/34180289/

Shields C.L., Srinivasan A., Lucio-Alvarez J.A., Shields J.A. Retinocytoma/retinoma: comparative analysis of clinical features in 78 tumors and rate of transformation into retinoblastoma over 20 years. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2021 May 26:S1091-8531(21)00132-4.
doi: 10.1016/j.jaapos.2020.11.024
https://pubmed.ncbi.nlm.nih.gov/34051357/

Silva-Teixeira R., Laranjo M., Lopes B., Almeida-Ferreira C., Gonçalves A.C., Rodrigues T., Matafome P., Sarmento-Ribeiro A.B., Caramelo F., Botelho M.F.
Plasma activated media and direct exposition can selectively ablate retinoblastoma cells. Free radical biology & medicine. 2021 May 20;171:302-313.
doi: 10.1016/j.freeradbiomed.2021.05.027.
https://pubmed.ncbi.nlm.nih.gov/34022401/

Silvera V.M., Guerin J.B., Brinjikji W., Dalvin L.A. Retinoblastoma: What the Neuroradiologist Needs to Know. AJNR. American journal of neuroradiology. 2021 Jan 28.
doi: 10.3174/ajnr.A6949.
https://pubmed.ncbi.nlm.nih.gov/33509920/

Singh L., Singh M.K., Rizvi M.A., Bakhshi S., Meel R., Lomi N., Sen S., Kashyap S. Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma.
DOI: 10.1007/s00262-020-02529-4

Skalet A.H., Allen R.C., Shields C.L., Wilson M.W., Mruthyunjaya P., Gombos D.S. Considerations for the Management and Triage of Ocular Oncology Cases during the COVID-19 Pandemic. Ocular oncology and pathology. 2020 Apr 21.
DOI: 10.1159/000507734
https://pubmed.ncbi.nlm.nih.gov/32411697/?from_term=retinoblastoma&from_sort=date&from_page=3&from_pos=6

Skilton A.M., Low L.G., Dimaras H. Patients, Public and Service Users are Experts by Experience: An Overview from Ophthalmology Research in Canada, UK and Beyond. Ophthalmol Ther. 2020 Feb 29.
DOI: 10.1007/s40123-020-00237-x.
https://link.springer.com/arti…/10.1007%2Fs40123-020-00237-x

Solana-Altabella A., Valero S., Balaguer J., Escobar-Cava P., Barranco H., López E., Ribes-Artero H., Poveda J.L. Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol. J Oncol Pharm Pract. 2020 Feb 17:1078155220904410.
DOI: 10.1177/1078155220904410

Soliman S.E., Martínez S., De Nicola M.L., Kiehl R., Krema H. Molecular analysis confirms retinoblastoma diagnosis in a histologically undifferentiated retinal tumor in an adult. Ophthalmic genetics. 2020 Jun 16.
doi: 10.1080/13816810.2020.1765398
https://pubmed.ncbi.nlm.nih.gov/32543965/

Soliman S.E., Bansal A., De Nicola M.L., Bhambhwani V., Laperriere N., Gallie B.L., Krema H. Applications of iodine-125 plaque radiotherapy for residual or recurrent retinoblastoma. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2021 Jan 23:S0008-4182(21)00001-6.
doi: 10.1016/j.jcjo.2020.12.016.
https://pubmed.ncbi.nlm.nih.gov/33493457/

Soliman S., Feng Z.X., Gallie B. Primary laser therapy as monotherapy for discrete retinoblastoma. The British journal of ophthalmology. 2021 Feb 3:bjophthalmol-2020-317885.
doi: 10.1136/bjophthalmol-2020-317885.
https://pubmed.ncbi.nlm.nih.gov/33536230/

Soliman S.E., Vanden Hoven C., MacKeen L.D., Gallie B.L. Secondary Prevention of Retinoblastoma Revisited: Laser Photocoagulation of Invisible New Retinoblastoma. Ophthalmology. 2020 Jan;127(1):122-127.
DOI: 10.1016/j.ophtha.2019.08.011.
https://www.aaojournal.org/a…/S0161-6420(19)31933-5/fulltext

Song L., Wang Y., Cui J., Zhang W., Zhang D., Wang X., Wang Z., Zhao Y., Zhang C., Duan C., Sun T., Zhang L., Yang X. Characteristics of Myelogram in Patients with Extraocular Metastatic Retinoblastoma and Morphological Analysis of Tumor Cells in Bone Marrow and Cerebrospinal Fluid.
Ophthalmologica. 2020 Oct 12.
doi: 10.1159/000512193.
https://pubmed.ncbi.nlm.nih.gov/33045702/

Song W.P., Zheng S., Yao H.J., Zhou X.F., Li R., Zhang C.Y., Zhao J.Y., Wang L.W., Shao R.G., Li L. Different transcriptome profiles between human retinoblastoma Y79 cells and an etoposide-resistant subline reveal a chemoresistance mechanism. // BMC Ophthalmology. 2020 Mar 6.
DOI: 10.1186/s12886-020-01348-6
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060629/

Song L., Huang Y., Zhang X., Han S., Hou M., Li H. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2. Investigative Ophthalmology & Visual Science.. 2020 Mar 9
DOI: 10.1167/iovs.61.3.32
https://pubmed.ncbi.nlm.nih.gov/32186675/?from_term=retinoblastoma&from_sort=pubdate&from_size=50&from_pos=49

Stacey A.W., Bowman R., Foster A., Kivelä T.T., Munier F.L., Cassoux N., Fabian I.D.; Global Retinoblastoma Study Group, Al Harby L., Alarcón Portabella S., Alia D.B., All-Eriksson C., Antonino R., Astbury N.J., Balaguer J., Balwierz W., Barranco H., Bascaran C., Beck Popovic M., Biewald E.M., Bobrova N., Bornfeld N., Brichard B.G., Blum S., Capra M., Castela G., Català-Mora J., Chantada G.L., Chernodrinska V.S., Cieslik K., Comsa C., Correa Llano M.G., Csóka M., De Potter P., Desjardins L., Dragomir M.D., Fernández-Teijeiro A., García Aldana D., Gregersen P.A., Gomel N., Hadjistilianou T., Hederova S., Hummlen M., Husakova K., Ida R., Ilic V.R., Jenkinson H., Kapelushnik N., Kardava T., Keren-Froim N., Kepak T., Khotenashvili Z., Klett A., Krivaitiene D., Latinović S., Lumbroso L., Lysytsia L., Maka E., Martín Begue N., Midena E., Moll A.C., Murgoi G., Naumenko L., Neroev V., Nikitovic M., Olechowski A., Papyan R., Parrozzani R., Parulekar M.V., Pawinska-Wasikowska K., Perić S., Pochop P., Polyakov V.G., Reddy M.A., Ritter-Sovinz P., Saakyan S., Sagoo M.S., San Román Pacheco S., Seregard S., Silva S., Sorochynska T., Stathopoulos C., Stirn Kranjc B., Svojgr K., Tamamyan G., Tandili A., Tateshi B., Tekavcic Pompe M., Urbak S.F., Ushakova T.L., Valeina S., van Hoefen Wijsard M., Veleva-Krasteva N.V., Viksnins M., Wackernagel W., Wolley Dod C., Yarovaya V.A., Yarovoy A.A., Zhilyaeva K., Zondervan M.
Incidence of retinoblastoma has increased: results from 40 European countries.
Ophthalmology. 2021 Jan 25:S0161-6420(21)00072-5.
doi: 10.1016/j.ophtha.2021.01.024.
https://pubmed.ncbi.nlm.nih.gov/33508429/

Stacey A.W., De Francesco S., Borri M., Hadjistilianou T. The addition of topotecan to melphalan in the treatment of retinoblastoma with intra-arterial chemotherapy. Ophthalmology. Retina. 2020 Nov 19:S2468-6530(20)30459-0.
doi: 10.1016/j.oret.2020.11.007.
https://pubmed.ncbi.nlm.nih.gov/33221516/

Stacey A.W., Tsukikawa M., Fabian I.D., Turner S., Jenkinson H., Smith V., Naeem Z., Morland B., Ainsworth J.R., Reddy M.A., Parulekar M., Sagoo M.S. Adjuvant use of laser in eyes with macular retinoblastoma treated with primary intravenous chemotherapy.The British journal of ophthalmology. 2020 Sep 15
doi: 10.1136/bjophthalmol-2020-316862.
https://pubmed.ncbi.nlm.nih.gov/32933939/

Stathopoulos C., Bartolini B., Marie G., Beck-Popovic M., Saliou G., Munier F.L. Risk factors for acute choroidal ischemia after intra-arterial melphalan for retinoblastoma: the role of the catheterization approach. Ophthalmology. 2020 Sep 18
doi: 10.1016/j.ophtha.2020.09.021.
https://pubmed.ncbi.nlm.nih.gov/32956742/

Stathopoulos C., Lumbroso-Le Rouic L., Moll A.C., Parulekar M., Maeder P., Doz F., Jenkinson H., Beck Popovic M., Chantada G., Munier F.L. Current Indications of Secondary Enucleation in Retinoblastoma Management: A Position Paper on Behalf of the European Retinoblastoma Group (EURbG). Cancers (Basel). 2021 Jul 6;13(14):3392. PMID: 34298608; PMCID: PMC8303810.
https://doi.org/10.3390/cancers13143392

Stathopoulos C., Sergenti J., Gaillard M.C., Munier F.L., Daruich A. Pars plana vitrectomy under melphalan irrigation for recurrent retinal detachment in eyes treated for retinoblastoma: a case report. BMC Ophthalmol. 2020 Jan 28;20(1):34.
DOI: 10.1186/s12886-020-1315-7

Sujjitjoon J., Sayour E., Tsao S.T., Uiprasertkul M., Sanpakit K., Buaboonnam J., Yenchitsomanus P.T., Atchaneeyasakul L.O., Chang L.J. GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma - assessing tumor and T cell interaction. Translational oncology. 2020 Dec 12;14(2):100971.
doi: 10.1016/j.tranon.2020.100971.
https://pubmed.ncbi.nlm.nih.gov/33321428/

Suleiman D.E., Iliyasu Y., Ahmed S.A., Liman A.A. Histopathologic spectrum of paediatric eye and ocular adnexal tumours: A 10-year review from a referral centre in Nigeria. Nigerian journal of clinical practice. 2020 May;23
DOI: 10.4103/njcp.njcp_389_19
https://pubmed.ncbi.nlm.nih.gov/32367872/?from_term=retinoblastoma&from_sort=date&from_page=5&from_pos=5

Sun J., Feng D., Xi H., Luo J., Zhou Z., Liu Q., Chen Y., Shao Q. CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy. Molecular oncology. 2020 May 12.
DOI: 10.1002/1878-0261.12708
https://pubmed.ncbi.nlm.nih.gov/32394616/?from_term=retinoblastoma&from_sort=date&from_page=4&from_pos=5

Sun J., Xi H.Y., Shao Q., Liu Q.H. Biomarkers in retinoblastoma Int J Ophthalmol. 2020 Feb 18;13(2):325-341. DOI: 10.18240/ijo.2020.02.18. eCollection 2020.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013786/

Sun S., Wang R., Yi S., Li S., Wang L., Wang J. Roles of the microRNA‑338‑3p/NOVA1 axis in retinoblastoma. Molecular medicine reports. 2021 May;23(5):394.
doi: 10.3892/mmr.2021.12033.
https://pubmed.ncbi.nlm.nih.gov/33760207/

Sun X., Shen H., Liu S., Gao J., Zhang S. Long noncoding RNA SNHG14 promotes the aggressiveness of retinoblastoma by sponging microRNA‑124 and thereby upregulating STAT3.International Journal of Molecular Medicine. 2020 Mar 20
DOI: 10.3892/ijmm.2020.4547
https://pubmed.ncbi.nlm.nih.gov/32236565/?from_term=retinoblastoma&from_sort=date&from_page=3&from_pos=5

Sun Z., Zhang A., Hou M., Jiang T. Circular RNA hsa_circ_0000034 promotes the progression of retinoblastoma via sponging microRNA-361-3p. Bioengineered. 2020 Dec;11(1):949-957.
doi: 10.1080/21655979.2020.1814670.
https://pubmed.ncbi.nlm.nih.gov/32892696/

Sweid A., El Naamani K., Sajja K.C., Hammoud B., Knapp M.D., Moylan D.D., Joffe D., Morse C.E., Habbal D., Weinberg J.H., Tjoumakaris S.I., Shields C.L., Lezama D.A., Lim L.S., Dalvin L.A., Rosenwasser R., Jabbour P. Incidence and predictors of ophthalmic artery occlusion in intra-arterial chemotherapy for retinoblastoma. Journal of neurointerventional surgery. 2020 Oct 29
doi: 10.1136/neurintsurg-2020-016759.
https://pubmed.ncbi.nlm.nih.gov/33122349/

Sweid A., Hammoud B., Texakalidis P., Xu V., Shivashankar K., Baldassari M.P., Das S., Tjoumakaris S., Shields C.L., Ancona-Lezama D., Lim L.S., Dalvin L.A., Maamari D.J., Jabbour P. The Use of Alternative Routes for the Delivery of Intra-Arterial Chemotherapy for Retinoblastoma.
Neurosurgery online. 2020 May 12.
DOI: 10.1093/neuros/nyaa142
https://pubmed.ncbi.nlm.nih.gov/32396190/?from_term=retinoblastoma&from_sort=date&from_page=4&from_pos=4

Sweid A., Hammoud B., Weinberg J.H., Texakalidis P., Xu V., Shivashankar K., Baldassari M.P., Das S., Ramesh S., Tjoumakaris S., Shields C.L., Ancona-Lezama D., Lim L.S., Dalvin L.A., Jabbour P. Intra-Arterial Chemotherapy for Retinoblastoma in Infants ≤10 Kg: 74 Treated Eyes With 222 IAC Sessions. American journal of neuroradiology. 2020 June 25.
doi: 10.3174/ajnr.A6590
https://pubmed.ncbi.nlm.nih.gov/32586963/

Sweid A., Jabbour P. Intra-arterial chemotherapy for retinoblastoma: transradial and transfemoral approach. Journal of neurointerventional surgery. 2020 May 15/
DOI: 10.1136/neurintsurg-2019-015627
https://pubmed.ncbi.nlm.nih.gov/32414893/?from_term=retinoblastoma&from_sort=date&from_page=3&from_pos=4

Sweid A., Hammoud B., Weinberg J.H., Texakalidis P., Xu V., Shivashankar K., Baldassari M.P., Das S., Tjoumakaris S.I., Shields C.L., Lezama D.A., Lim L.S., Dalvin L.A., El Naamani K., Jabbour P. Ophthalmic artery catheterization for retinoblastoma treatment: does reflux affect tumor response? Journal of NeuroInterventional Surgery. 2020 Apr 9
DOI: 10.1136/neurintsurg-2019-015597
https://pubmed.ncbi.nlm.nih.gov/32277036/?from_term=retinoblastoma&from_sort=date&from_pos=7
T

Tandon S., Prasad M., Vora T., Chinnaswamy G., Shetye N. A Rare Association of Retinoblastoma With Incontinentia Pigmenti. Journal of Pediatric Hematology/Oncology. 2020 Apr 13.
DOI: 10.1097/MPH.0000000000001797
https://pubmed.ncbi.nlm.nih.gov/32287098/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=10

Taneja S., Aldoais T., Kaliki S. Primary Orbital Polymethylmethacrylate Implant Following Primary Enucleation for Retinoblastoma: A Study of 321 Cases. Orbit. 2020 Apr 7
DOI: 10.1080/01676830.2020.1750040
https://pubmed.ncbi.nlm.nih.gov/32252576/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=9

Taneja S., Aldoais T., Kaliki S. Primary orbital polymethylmethacrylate implant following primary enucleation for retinoblastoma: a study of 321 cases. Orbit. 2021 Apr;40(2):127-132.
doi: 10.1080/01676830.2020.1750040.
https://pubmed.ncbi.nlm.nih.gov/32252576/

Ting S.C., Kiefer T., Ehlert K., Goericke S.L., Hinze R., Ketteler P., Bechrakis N.E., Schildhaus H.U. Bone metastasis of retinoblastoma five years after primary treatment. American journal of ophthalmology case reports. 2020 Jul 17
doi: 10.1016/j.ajoc.2020.100834.
https://pubmed.ncbi.nlm.nih.gov/32715161/

Tomar A.S., Finger P.T., Gallie B., Mallipatna A., Kivelä T.T., Zhang C., Zhao J., Wilson M.W., Brenna R.C., Burges M., Kim J., Khetan V., Ganesan S., Yarovoy A., Yarovaya V., Kotova E., Yousef Y.A., Nummi K, Ushakova T.L., Yugay O.V., Polyakov V.G., Ramirez-Ortiz M.A., Esparza-Aguiar E., Chantada G., Schaiquevich P., Fandino A., Yam J.C., Lau W.W., Lam C.P., Sharwood P., Moorthy S., Long Q.B., Essuman V.A., Renner L.A., Semenova E., Català J., Correa-Llano G., Carreras-Bertran E.; American Joint Committee on Cancer Ophthalmic Oncology Task Force. A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Treatment Success and Globe Salvage. Ophthalmology. 2020 Jun 8.
doi: 10.1016/j.ophtha.2020.05.051
https://pubmed.ncbi.nlm.nih.gov/32526306/

Tomar A.S., Finger P.T., Gallie B., Kivelä T.T., Mallipatna A., Zhang C., Zhao J., Wilson M.W., Brenna R.C., Burges M., Kim J., Khetan V., Ganesan S., Yarovoy A., Yarovaya V., Kotova E., Yousef Y.A., Nummi K., Ushakova T.L., Yugay O.V., Polyakov V.G., Ramirez-Ortiz M.A., Esparza-Aguiar E., Chantada G., Schaiquevich P., Fandino A., Yam J.C., Lau W.W., Lam C.P., Sharwood P., Moorthy S., Long Q.B., Essuman V.A., Renner L.A., Semenova E., Català J., Correa-Llano G., Carreras E.; American Joint Committee on Cancer Ophthalmic Oncology Task Force.
Global Retinoblastoma Treatment Outcomes: Association with National Income Level. Ophthalmology. 2021 May;128(5):740-753.
doi: 10.1016/j.ophtha.2020.09.032.
https://pubmed.ncbi.nlm.nih.gov/33007338/

Tomita T., Huibregtse J.M., Matouschek A. A Masked Initiation Region in Retinoblastoma Protein Regulates Its Proteasomal Degradation. Nature Communications. 2020 Apr 24
DOI: 10.1038/s41467-020-16003-3
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181824/

Tonorezos E.S., Friedman D.N., Barnea D., Bosscha M.I., Chantada G., Dommering C.J., de Graaf P., Dunkel I.J., Fabius A.W.M., Francis J.H., Greer M.C., Kleinerman R.A., Kors W.A., Laughlin S., Moll A.C., Morton L.M., Temming P., Tucker M.A., van Leeuwen F.E., Walsh M.F., Oeffinger K.C., Abramson D.H. Recommendations for long-term follow-up of adults with heritable retinoblastoma. Ophthalmology. 2020 May 15.
DOI: 10.1016/j.ophtha.2020.05.024
https://pubmed.ncbi.nlm.nih.gov/32422154/?from_term=retinoblastoma&from_sort=date&from_page=3&from_pos=1

Turchiello R.F., Oliveira C.S., Fernandes A.U., Gómez S.L., Baptista M.S. Methylene blue-mediated Photodynamic Therapy in human retinoblastoma cell lines. Journal of photochemistry and photobiology. B, Biology. 2021 Jul 16;222:112260. PMID: 34304071.
doi: 10.1016/j.jphotobiol.2021.112260.
https://pubmed.ncbi.nlm.nih.gov/34304071/

Turkoglu E.B., Erol M.K., Karaca B.O. Coexistence of torpedo maculopathy and retinoblastoma: Differentiation the lesions with hand-held optical coherence tomography. Photodiagnosis and photodynamic therapy. 2021 May 4;34:102331.
doi: 10.1016/j.pdpdt.2021.102331.
https://pubmed.ncbi.nlm.nih.gov/33962056/

Turkoglu E.B., Erol M.K. Optical coherence tomography findings in a case with cavitary retinoblastoma. Journal français d'ophtalmologie. 2020 Dec 1:S0181-5512(20)30536-2.
doi: 10.1016/j.jfo.2020.05.008.
https://pubmed.ncbi.nlm.nih.gov/33277083/
U

Ueda T., Koga Y., Yoshikawa H., Tanabe M., Yamana K., Oba U., Nakashima K., Ono H., Ichimura T., Hasegawa S., Kato W., Kobayashi T., Nakayama H., Sakai Y., Yoshitake T., Ohga S., Oda Y., Suzuki S., Sonoda K.H., Ohga S. Survival and ocular preservation in a long-term cohort of Japanese patients with retinoblastoma. BMC Pediatr. 2020 Jan 28;20(1):37.
DOI: 10.1186/s12887-020-1923-7
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986142/

V

van Hoefen Wijsard M., Serné S.H., Otten R.H., Bosscha M.I., Dommering C.J., Fabius A.W., Moll A.C. At What Age Could Screening for Familial Retinoblastoma Be Discontinued? A Systematic Review. Cancers. 2021 Apr 17;13(8):1942.
doi: 10.3390/cancers13081942.
https://pubmed.ncbi.nlm.nih.gov/33920538/

van Hoefen Wijsard M., Schonfeld S.J., van Leeuwen F.E., Moll A.C., Fabius A.W., Abramson D.H., Seddon J.M., Francis J.H., Tucker M.A., Kleinerman R.A., Morton L.M. Benign Tumors in Long-Term Survivors of Retinoblastoma. Cancers. 2021 Apr 8;13(8):1773.
doi: 10.3390/cancers13081773.
https://pubmed.ncbi.nlm.nih.gov/33917779/

Vempuluru V.S., Jakati S., Kaliki S. Delayed metastasis in patients with intraocular retinoblastoma: A review of three cases. European journal of ophthalmology. 2020 Jul 24.
doi: 10.1177/1120672120946285.
https://pubmed.ncbi.nlm.nih.gov/32703017/

Vempuluru V.S, Jakati S., Krishnamurthy R., Senthil S., Kaliki S. Glaucoma as the presenting sign of intraocular tumors: beware of the masquerading sign. // International Ophthalmology. 2020 Mar 20.
DOI: 10.1007/s10792-020-01348-x.
https://pubmed.ncbi.nlm.nih.gov/32198607/?from_term=retinoblastoma&from_sort=date&from_pos=5

Vempuluru V.S., Kaliki S. Screening for Retinoblastoma: A Systematic Review of Current Strategies. Asia-Pacific journal of ophthalmology. 2021 Mar-Apr 01;10(2):192-199.
doi: 10.1097/APO.0000000000000378.
https://pubmed.ncbi.nlm.nih.gov/33793441/
W

Waddell K., Matua M., Bidwell C., Atwine R., Onyango J., Picton S.V., Simmons I., Stahlschmidt J., Johnston W.T., Newton R. A ten-year study of Retinoblastoma in Uganda: An approach to improving outcome with limited resources. Cancer epidemiology. 2020 Jul 10
doi: 10.1016/j.canep.2020.101777
https://pubmed.ncbi.nlm.nih.gov/32660850/

Waddell K., Matua M., Bidwell C., Atwine R., Onyango J., Picton S.V., Simmons I., Stahlschmidt J., Johnston W.T., Newton R. A ten-year study of Retinoblastoma in Uganda: An approach to improving outcome with limited resources. Cancer Epidemiology. 2021 Apr;71(Pt B):101777.
doi: 10.1016/j.canep.2020.101777.
https://pubmed.ncbi.nlm.nih.gov/32660850/

Wang H., Li M., Cui H., Song X., Sha Q. CircDHDDS/miR-361-3p/WNT3A Axis Promotes the Development of Retinoblastoma by Regulating Proliferation, Cell Cycle, Migration, and Invasion of Retinoblastoma Cells. Neurochemical research. 2020 Aug 31.
doi: 10.1007/s11064-020-03112-0.
https://pubmed.ncbi.nlm.nih.gov/32865704/

Wang H., Yang J., Pan H., Tai M.C., Maher M.H., Jia R., Ge S., Lu L. Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway. OncoTargets and therapy.2020 May 8.
DOI: 10.2147/OTT.S228532
https://pubmed.ncbi.nlm.nih.gov/32440155/?from_term=retinoblastoma&from_sort=date&from_pos=6

Wang J., Dong Y., Li Q. Neferine induces mitochondrial dysfunction to exert anti-proliferative and anti-invasive activities on retinoblastoma. Experimental biology and medicine / Society for Experimental Biology and Medicine. 2020 May 28
DOI: 10.1177/1535370220928933
https://pubmed.ncbi.nlm.nih.gov/32460625/?from_term=retinoblastoma&from_sort=date&from_pos=2

Wang J., Wang S., Chen L., Tan J. SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway.Molecular medicine reports. 2021 Mar;23(3):202.
doi: 10.3892/mmr.2021.11841. Epub 2021 Jan 26
https://pubmed.ncbi.nlm.nih.gov/33495818/

Wang L., Chen N., Cheng H. Fisetin inhibits vascular endothelial growth factor-induced angiogenesis in retinoblastoma cells. Oncology letters. 2020 Aug.
doi: 10.3892/ol.2020.11679
https://pubmed.ncbi.nlm.nih.gov/32724364/

Wang L., Wang C., Wu T., Sun F. Long non-coding RNA TP73-AS1 promotes TFAP2B-mediated proliferation, metastasis and invasion in retinoblastoma via decoying of miRNA-874-3p. Journal of Cell Communication and Signaling. Feb-2020.
DOI 10.1007/s12079-020-00550-x
https://link.springer.com/arti…/10.1007%2Fs12079-020-00550-x

Wang L., Zhang Y., Xin X. Long Non-Coding RNA MALAT1 Aggravates Human Retinoblastoma by Sponging miR-20b-5p to Upregulate STAT3. Pathology, Research and Practice. 2020 Apr 18.
DOI: 10.1016/j.prp.2020.152977
https://pubmed.ncbi.nlm.nih.gov/32336590/?from_term=retinoblastoma&from_sort=date&from_pos=5

Wang Y., Sun D., Sheng Y., Guo H., Meng F., Song T. XIST promotes cell proliferation and invasion by regulating miR-140-5p and SOX4 in retinoblastoma // World Journal of Surgical Oncology. 2020 Mar 3.
DOI: 10.1186/s12957-020-01825-8
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055023/

Wang Y., Wang J., Hao H., Luo X. lncRNA KCNQ1OT1 promotes the proliferation, migration and invasion of retinoblastoma cells by upregulating HIF-1alpha via sponging miR-153-3p. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 2020 Dec;68(8):1349-1356.
doi: 10.1136/jim-2020-001431.
https://pubmed.ncbi.nlm.nih.gov/33051357/

Wang Y., Xin D., Zhou L. LncRNA LINC00152 Increases the Aggressiveness of Human Retinoblastoma and Enhances Carboplatin and Adriamycin Resistance by Regulating MiR-613/Yes-Associated Protein 1 (YAP1) Axis. Medical science monitor : international medical journal of experimental and clinical research.2020 Jun 15.
doi: 10.12659/MSM.920886.
https://pubmed.ncbi.nlm.nih.gov/32541644/

Wang Y.Z., Zhang Y., Huang D.S., Shi J.T., Ma J.M., Li B., Xu X.L., Zhou Y., Gu H.L.
Clinical characteristics, treatment and prognosis of children with unilateral retinoblastoma and intracranial segment of Retrobulbar optic nerve invasion.
BMC Ophthalmol. 2021 Jan 14;21(1):38.
doi: 10.1186/s12886-020-01768-4.
https://pubmed.ncbi.nlm.nih.gov/33446150/

Wan W., Wan W., Long Y., Li Q., Jin X., Wan G., Zhang F., Lv Y., Zheng G., Li Z., Zhu Y. Corrigendum to "MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway" [Biomed. Pharmacother. 118 (2019) 109111]. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie. 2020 Oct 19:110842.
doi: 10.1016/j.biopha.2020.110842.
https://pubmed.ncbi.nlm.nih.gov/33092949/

Weng P.Y., Chen S.H., Kao L.Y., Tsai Y.J., Yang S.H., Tseng C.K., Tsay P.K., Jaing T.H. Clinical spectrum and treatment outcome of retinoblastoma with Group D and E diseases: A single institution retrospective review. Medicine. 2020 Sep 18;
doi: 10.1097/MD.0000000000022201.
https://pubmed.ncbi.nlm.nih.gov/32957352/

Willard V.W., Qaddoumi I., Pan H., Hsu C.W., Brennan R.C., Wilson M.W., Rodriguez-Galindo C., Goode K., Parris K., Phipps S. Cognitive and Adaptive Functioning in Youth With Retinoblastoma: A Longitudinal Investigation Through 10 Years of Age. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021 Apr 23:JCO2003422.
doi: 10.1200/JCO.20.03422.
https://pubmed.ncbi.nlm.nih.gov/33891476/

Winter U., Ganiewich D., Ottaviani D., Zugbi S., Aschero R., Sendoya J.M., Cafferata E.G., Mena M., Sgroi M., Sampor C., Lubieniecki F., Fandiño A., Abba M.C., Doz F., Podhjacer O., Montero Carcaboso A., Letouzé E., Radvanyi F., Chantada G.L., Llera A.S., Schaiquevich P. Genomic and Transcriptomic Tumor Heterogeneity in Bilateral Retinoblastoma // JAMA Ophthalmology. 2020 Mar 19.
DOI: 10.1001/jamaophthalmol.2020.0427
https://pubmed.ncbi.nlm.nih.gov/32191268/?from_term=retinoblastoma&from_sort=date&from_pos=1

Wiwatwongwana D., Kulniwatcharoen P., Mahanupab P., Visrutaratna P., Wiwatwongwana A. Accuracy of Computed Tomography and Magnetic Resonance Imaging for Detection of Pathologic Risk Factors in Patients Diagnosed with Retinoblastoma. Current eye research. 2021 Mar 22:1-7.
doi: 10.1080/02713683.2021.1901938.
https://pubmed.ncbi.nlm.nih.gov/33752572/

Wong E.Y., Xu L., Shen L., Kim M.E., Polski A., Prabakar R.K., Shah R., Jubran R., Kim J.W., Biegel J.A., Gai X., Kuhn P., Hicks J., Berry J.L. Inter-eye genomic heterogeneity in bilateral retinoblastoma via aqueous humor liquid biopsy. NPJ precision oncology. 2021 Jul 27;5(1):73. PMID: 34316014; PMCID: PMC8316348.
doi: 10.1038/s41698-021-00212-0.
https://pubmed.ncbi.nlm.nih.gov/34316014/

Wu C., Shang X.Q., You Z.P., Jin Q.F., Zhang Y.L., Zhou Y., Zhang Y.Z., Shi K. TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway. Investigative ophthalmology & visual science. 2020 Aug 3
doi: 10.1167/iovs.61.10.2.
https://pubmed.ncbi.nlm.nih.gov/32744597/

Wu J., Qian D., Sun X. Long noncoding RNAs as potential biomarkers in retinoblastoma: a systematic review and meta-analysis. Cancer cell international. 2020 May 29.
doi: 10.1186/s12935-020-01281-0.
https://pubmed.ncbi.nlm.nih.gov/32514246/

Wu Z., Chen L., Zhang C., Liu Y. miR-4319 inhibited retinoblastoma cells proliferation, migration, invasion and EMT progress via suppressing CD147 mediated MMPs expression. Journal of molecular histology. 2021 Jan 20.
doi: 10.1007/s10735-020-09946-w.
https://pubmed.ncbi.nlm.nih.gov/33474692/
X

Xia Y., Deng Y., Zhou Y., Li D., Sun X., Gu L., Chen Z., Zhao Q. TSPAN31 suppresses cell proliferation in human cervical cancer through down-regulation of its antisense pairing with CDK4. // Cell Biochemistry & Function. 2020 Mar 23
DOI: 10.1002/cbf.3526.
https://pubmed.ncbi.nlm.nih.gov/32207169/?from_term=retinoblastoma&from_sort=date&from_pos=2

Xiao W., Ji X., Ye H., Zeng H., Gao Y., Chen R., Chen X., Mao Y., Yang H. Parent Knowledge of Screening and Genetic Testing in Retinoblastoma. Journal of ophthalmology. 2020 Apr 8
DOI: 10.1155/2020/3839792
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171634/

Xu K., Liu J., Zhang C. Intra-arterial chemotherapy combined with VEC intravenous chemotherapy in the treatment of advanced retinoblastoma. Journal of B.U.ON. : official journal of the Balkan Union of Oncology. Mar-Apr 2020.
https://jbuon.com/archive/25-2-1199.pdf

Xu L., Kim M.E., Polski A., Prabakar R.K., Shen L., Peng C.C., Reid M.W, Chévez-Barrios P, Kim J.W., Shah R., Jubran R., Kuhn P., Cobrinik D., Biegel J.A., Gai X., Hicks J., Berry J.L. Establishing the Clinical Utility of ctDNA Analysis for Diagnosis, Prognosis, and Treatment Monitoring of Retinoblastoma: The Aqueous Humor Liquid Biopsy. Cancers. 2021 Mar 13;13(6):1282.
doi: 10.3390/cancers13061282.
https://pubmed.ncbi.nlm.nih.gov/33805776/

Xu L., Long H., Zhou B., Jiang H., Cai M. CircMKLN1 Suppresses the Progression of Human Retinoblastoma by Modulation of miR-425-5p/PDCD4 Axis. Current eye research. 2021 May 14:1-11.
doi: 10.1080/02713683.2021.1927110.
https://pubmed.ncbi.nlm.nih.gov/33988065/

Xu L., Polski A., Prabakar R.K., Reid M.W., Chevez-Barrios P., Jubran R., Kim J.W., Kuhn P., Cobrinik D., Hicks J., Berry J.L. Chromosome 6p amplification in aqueous humor cell-free DNA is a prognostic biomarker for retinoblastoma ocular survival. Molecular cancer research : MCR. 2020 May 20.
DOI: 10.1158/1541-7786.MCR-19-1262
https://pubmed.ncbi.nlm.nih.gov/32434859/?from_term=retinoblastoma&from_sort=date&from_pos=9

Xu L., Shen L., Polski A., Prabakar R.K., Shah R., Jubran R., Kim J.W., Biegel J., Kuhn P., Cobrinik D., Hicks J., Gai X., Berry J.L. Simultaneous identification of clinically relevant RB1 mutations and copy number alterations in aqueous humor of retinoblastoma eyes.
Ophthalmic genetics. 2020 Aug 17
doi: 10.1080/13816810.2020.1799417.
https://pubmed.ncbi.nlm.nih.gov/32799607/

Xu L., Zhu S., Tang A., Liu W. LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/beta-catenin signaling pathway. Inflammation research : official journal of the European Histamine Research Society ... [et al.].. 2021 Jan 16.
doi: 10.1007/s00011-020-01432-z.
https://pubmed.ncbi.nlm.nih.gov/33454803/

Xu Q. The Potential Tumor Promotional Role of circVAPA in Retinoblastoma via Regulating miR-615-3p and SMARCE1. OncoTargets and therapy. 2020 Aug 5
doi: 10.2147/OTT.S254925.
https://pubmed.ncbi.nlm.nih.gov/32848418/

Y

Yang H., Huang Y., He J., Chai G., Di Y., Wang A., Gui D. MiR-486-3p Inhibits the Proliferation, Migration and Invasion of Retinoblastoma Cells by Targeting ECM1.2020 May 13. Bioscience reports.
DOI: 10.1042/BSR20200392
https://pubmed.ncbi.nlm.nih.gov/32401301/?from_term=retinoblastoma&from_sort=date&from_page=3&from_pos=9

Yang L., Zhang L., Lu L., Wang Y. miR-214-3p Regulates Multi-Drug Resistance and Apoptosis in Retinoblastoma Cells by Targeting ABCB1 and XIAP. Onco Targets Ther. 2020 Jan 28;13:803-811.
DOI: 10.2147/OTT.S235862. eCollection 2020.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995305/

Yang M.K., Lee M.J., Kim N., Choung H., Khwarg S.I. Outcomes of enucleation and porous polyethylene orbital implant insertion in patients with paediatric retinoblastoma: a long-term follow-up study. The British journal of ophthalmology. 2020 Dec 8:bjophthalmol-2020-317934.
doi: 10.1136/bjophthalmol-2020-317934.
https://pubmed.ncbi.nlm.nih.gov/33293268/

Yang X.L., Hao Y.J., Wang B., Gu X.L., Wang X.X., Sun J.F. Long noncoding RNA NORAD promotes the progression of retinoblastoma by sponging miR-136-5p/PBX3 axis. Eur Rev Med Pharmacol Sci. 2020 Jan;24(3):1278-1287.
DOI: 10.26355/eurrev_202001_20185.
https://www.europeanreview.org/article/20185

Yang Y.L., Zhou H., Yue L.R., Shen H. Spleen tyrosine kinase expression and its correlation with necrosis and high-risk histopathologic features in retinoblastoma. Chinese medical journal. 2020 Jul 20.
doi: 10.1097/CM9.0000000000000889.
https://pubmed.ncbi.nlm.nih.gov/32649521/

Yao L., Yang L., Song H., Liu T.G., Yan H. Silencing of lncRNA XIST Suppresses Proliferation and Autophagy and Enhances Vincristine Sensitivity in Retinoblastoma Cells by Sponging miR-204-5p. European review for medical and pharmacological sciences. 2020 Apr 24.
DOI: 10.26355/eurrev_202004_20812
https://pubmed.ncbi.nlm.nih.gov/32329826/?from_term=retinoblastoma&from_sort=date&from_pos=8

Yao X., Shen H., Peng Q., Yu J. TP53/miR-129/MDM2/4/TP53 feedback loop modulates cell proliferation and apoptosis in retinoblastoma. Cell Cycle. 2021 Mar-Mar;20(5-6):603-615.
doi: 10.1080/15384101.2021.1892321.
https://pubmed.ncbi.nlm.nih.gov/33678118/

Yazici H., Wu H.C., Tigli H., Yilmaz E.Z., Kebudi R., Santella R.M. High levels of global genome methylation in patients with retinoblastoma. Oncology letters. 2020 Jul
doi: 10.3892/ol.2020.11613
https://pubmed.ncbi.nlm.nih.gov/32565997/

Yin W., Gao F., Zhang S. MicroRNA‑34a inhibits the proliferation and promotes the chemosensitivity of retinoblastoma cells by downregulating Notch1 expression. Molecular medicine reports. 2020 Aug;22
doi: 10.3892/mmr.2020.11238
https://pubmed.ncbi.nlm.nih.gov/32626991/

Yousef Y.A., Al Jboor M., Mohammad M., Mehyar M., Toro M.D., Nazzal R., Alzureikat Q.H., Rejdak M., Elfalah M., Sultan I., Rejdak R., Al-Hussaini M., Al-Nawaiseh I. Safety and Efficacy of Intravitreal Chemotherapy (Melphalan) to Treat Vitreous Seeds in Retinoblastoma. Frontiers in pharmacology. 2021 Jul 12;12:696787. PMID: 34322023; PMCID: PMC8311556.
doi: 10.3389/fphar.2021.696787.
https://pubmed.ncbi.nlm.nih.gov/34322023/

Yu X., Li X., Xing Y., Lu S., Tanumiharjo S., Ma J. Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma. BMC Cancer. 2020 Aug 26
doi: 10.1186/s12885-020-07314-1.
https://pubmed.ncbi.nlm.nih.gov/32847550/

Yin X., Liao Y., Xiong W., Zhang Y., Zhou Y., Yang Y. Hypoxia-induced lncRNA ANRIL promotes cisplatin resistance in retinoblastoma cells through regulating ABCG2 expression.
Clinical and Experimental Pharmacology & Physiology.. 2020 Mar 15.
DOI: 10.1111/1440-1681.13279
https://pubmed.ncbi.nlm.nih.gov/32173903/?from_term=retinoblastoma&from_sort=pubdate&from_size=50&from_pos=41

Yousef Y.A., Alkhoms A., AlJabari R., AlJboor M., Mohammad M., Lahlouh M, Deebajah R, Halalsheh H, Al-Hussaini M, Jaradat I, Shawagfeh M, Sultan I, Mehyar M, AlNawaiseh I. Programmed screening for retinoblastoma enhances early diagnosis and improves management outcome for high-risk children. Ophthalmic genetics. 2020 May 20
DOI: 10.1080/13816810.2020.1766085
https://pubmed.ncbi.nlm.nih.gov/32432497/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=1

Yousef Y.A., Al-Nawaiseh I., Mehyar M, Sultan I., Al-Hussaini M., Jaradat I., Mohammad M., AlJabari R., Abu-Yaghi N., Rodriguez-Galindo C., Qaddoumi I., Wilson M. How Telemedicine and Centralized Care Changed the Natural History of Retinoblastoma in a Developing Country: Analysis of 478 Patients. Ophthalmology. 2020 Jul 16.
doi: 10.1016/j.ophtha.2020.07.026.
https://pubmed.ncbi.nlm.nih.gov/32682835/

Yousef Y.A., Mohammad M., Jaradat I., Shatnawi R., Banat S., Mehyar M., Al-Nawaiseh I. The role of external beam radiation therapy for retinoblastoma after failure of combined chemoreduction and focal consolidation therapy. Ophthalmic Genet. 2020 Feb 19:1-6.
DOI: 10.1080/13816810.2020.1719519.

Yousef Y.A., Mohammad M., Mehyar M., Sultan I., Al-Hussaini M., Alhourani J., Halalsheh H, Khzouz J., Jaradat I., Qaddoumi I., Al-Nawaiseh I. The Predictive Value of the Eighth Edition of the Clinical TNM Staging System for the Likelihood of Eye Salvage for Intraocular Retinoblastoma by Systemic Chemotherapy and Focal Therapy. Journal of pediatric hematology/oncology. 2021 Mar 23.
doi: 10.1097/MPH.0000000000002144.
https://pubmed.ncbi.nlm.nih.gov/33769386/

Yu B., Zhao J., Dong Y. Circ_0000527 Promotes Retinoblastoma Progression through Modulating miR-98-5p/XIAP Pathway. Current eye research. 2021 Feb 25:1-10.
doi: 10.1080/02713683.2021.1891255.
https://pubmed.ncbi.nlm.nih.gov/33629639/
Z

Zanolli M., Oporto J.I., Verdaguer J.I., López J.P., Zacharías S., Romero P., Ossandón D., Denk O., Acuña O., López J.M., Stevenson R., Álamos B., Iturriaga H. Genetic testing for inherited ocular conditions in a developing country. // Ophthalmic Genetics. 2020 Mar 6.
DOI: 10.1080/13816810.2020.1734944
https://www.ncbi.nlm.nih.gov/pubmed/32141364

Zeng Q., Wang S., Tan J., Chen L., Wang J. The methylation level of TFAP2A is a potential diagnostic biomarker for retinoblastoma: an analytical validation study. PeerJ. 2021 Mar 2;9:e10830.
doi: 10.7717/peerj.10830.
https://pubmed.ncbi.nlm.nih.gov/33717678/

Zeng Y., He T., Liu J., Li Z., Xie F., Chen C. Xing Y. Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma. Medicine. 2020 Nov 20;99(47):e23314.
doi: 10.1097/MD.0000000000023314.
https://pubmed.ncbi.nlm.nih.gov/33217867/

Zhang C., Feng Z.X., Li L., Solarte C.E., Ma X. Retinoblastoma in a child with tuberous sclerosis complex. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2020 Aug 18
doi: 10.1016/j.jcjo.2020.05.014.
https://pubmed.ncbi.nlm.nih.gov/32822658/

Zhang C., Wu S. MicroRNA -378a-3p Restrains the Proliferation of Retinoblastoma Cells but Promotes Apoptosis of Retinoblastoma Cells via Inhibition of FOXG1.
Investigative ophthalmology & visual science. 2020 May 11
DOI: 10.1167/iovs.61.5.31
https://pubmed.ncbi.nlm.nih.gov/32428232/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=7

Zhang G., Yang W., Li D., Li X., Huang J., Huang R., Luo J. lncRNA FEZF1‑AS1 promotes migration, invasion and epithelial‑mesenchymal transition of retinoblastoma cells by targeting miR‑1236‑3p. Molecular medicine reports. 2020 Sep 2
doi: 10.3892/mmr.2020.11478.
https://pubmed.ncbi.nlm.nih.gov/32901841/

Zhang H., Yang X., Xu Y., Li H. KCNQ1OT1 regulates the retinoblastoma cell proliferation, migration and SIRT1/JNK signaling pathway by targeting miR-124/SP1 axis. Bioscience reports. 2020 Dec 21:BSR20201626.
doi: 10.1042/BSR20201626.
https://pubmed.ncbi.nlm.nih.gov/33345272/

Zhang H., Zhang P., Long C., Ma X., Huang H., Kuang X., Du H., Tang H., Ling X., Ning J., Liu H., Deng X., Zou Y., Wang R., Cheng H., Lin S., Zhang Q., Yan J., Shen H. m(6)A methyltransferase METTL3 promotes retinoblastoma progression via PI3K/AKT/mTOR pathway. Journal of cellular and molecular medicine. 2020 Oct 8.
doi: 10.1111/jcmm.15736.
https://pubmed.ncbi.nlm.nih.gov/33090698/

Zhang L., Wu J., Li Y., Jiang Y., Wang L., Chen Y., Lv Y., Zou Y., Ding X.
Circ_0000527 promotes the progression of retinoblastoma by regulating miR-646/LRP6 axis. Cancer cell international. 2020 Jul 10
doi: 10.1186/s12935-020-01396-4.
https://pubmed.ncbi.nlm.nih.gov/32669977/
https://cancerci.biomedcentral.com/articles/10.1186/s12935-020-01396-4

Zhang R., Song Y.N., Duo X., Guo Z., Sun Y., Zhang Z., Lu Y., Miao B., Yang P.C., Nie G. Retinoblastoma cell-derived Twist protein promotes regulatory T-cell development. Cancer immunology, immunotherapy: CII. 2020 Oct 27.
doi: 10.1007/s00262-020-02744-z.
https://pubmed.ncbi.nlm.nih.gov/33108472/

Zhang S., Long J., Hu Y. Long noncoding RNA LINC00205 enhances the malignant characteristics of retinoblastoma by acting as a molecular sponge of microRNA-665 and consequently increasing HMGB1 expression. // Biochemical and Biophysical Research Communication. 2020 Mar 26.
DOI: 10.1016/j.bbrc.2020.03.083.
https://pubmed.ncbi.nlm.nih.gov/32223925/?from_term=retinoblastoma&from_sort=date&from_pos=1

Zhang T., Yang J., Gong F., Li L., Li A. Long non-coding RNA CASC9 promotes the progression of retinoblastoma via interacting with miR-145-5p. Cell Cycle. 2020 Aug 10.
doi: 10.1080/15384101.2020.1802813
https://pubmed.ncbi.nlm.nih.gov/32772636/

Zhang X., Song L., Huang Y., Han S., Hou M., Li H. Downregulation of MST4 Underlies a Novel Inhibitory Role of MicroRNA Let-7a in the Progression of Retinoblastoma.
Investigative ophthalmology & visual science. 2020 Jun 3.
doi: 10.1167/iovs.61.6.28.
https://pubmed.ncbi.nlm.nih.gov/32539131/

Zhang Y., Duan S., Jang A., Mao L., Liu X., Huang G. JQ1, a selective inhibitor of BRD4, suppresses retinoblastoma cell growth by inducing cell cycle arrest and apoptosis. Experimental eye research. 2020 Oct 17.
doi: 10.1016/j.exer.2020.108304.
https://pubmed.ncbi.nlm.nih.gov/33080301/

Zhang Y., Wang Y., Huang D., Ma J., Zhang W., Gu H., Zhou Y., Yi Y., Zhang P. Correlation between Family RB1 Gene Pathogenic Variant with Clinical Features and Prognosis of Retinoblastoma under 5 Years Old. Disease markers. 2021 Jul 12;2021:9981028. PMID: 34336010; PMCID: PMC8292087.
doi: 10.1155/2021/9981028.
https://pubmed.ncbi.nlm.nih.gov/34336010/

Zhang Z., Xiao Y.S., Shen R., Jiang H.C., Tan L., Li R.Q., Yang X.H., Gu H.Y., He W.J., Ma J. Next generation sequencing of RB1gene for the molecular diagnosis of ethnic minority with retinoblastoma in Yunnan. BMC medical genetics. 2020 Nov 23;21(1):230.
doi: 10.1186/s12881-020-01150-7
https://pubmed.ncbi.nlm.nih.gov/33225895/

Zhao H., Wan J., Zhu Y. Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 Axis. Drug design, development and therapy. 2020 Aug 21
doi: 10.2147/DDDT.S256813.
https://pubmed.ncbi.nlm.nih.gov/32904674/

Zhao N.O., Pak D., El-Hadad C., Debnam J.M., Ning J., Esmaeli B. Characteristics and Survival Outcomes of Second Primary Cancers in Long-term Retinoblastoma Survivors. Asia-Pacific journal of ophthalmology. 2021 Jan 19.
doi: 10.1097/APO.0000000000000361.
https://pubmed.ncbi.nlm.nih.gov/33481394/

Zhao X.M., Li Y.B., Sun P., Pu Y.D., Shan M.J., Zhang Y.M. Bioinformatics analysis of key biomarkers for retinoblastoma. The Journal of international medical research. 2021 Jun;49(6):3000605211022210.
doi: 10.1177/03000605211022210.
https://pubmed.ncbi.nlm.nih.gov/34187205/

Zheng T., Chen W., Wang X., Cai W., Wu F., Lin C. Circular RNA circ-FAM158A promotes retinoblastoma progression by regulating miR-138-5p/SLC7A5 axis. Experimental eye research. 2021 Jun 5:108650.
doi: 10.1016/j.exer.2021.108650.
https://pubmed.ncbi.nlm.nih.gov/34102206/

Zheng Q., Zhu Q., Li C., Hao S., Li J., Yu X., Qi D., Pan Y. Sinomenine can inhibit the growth and invasion ability of retinoblastoma cell through regulating PI3k/AKT signaling pathway. Biological & pharmaceutical bulletin. 2020 Aug 4.
doi: 10.1248/bpb.b20-00387.
https://pubmed.ncbi.nlm.nih.gov/32759601/

Zheng Y., Froehler M.T., Friedman D., Daniels A. Intra-arterial chemotherapy (IAC) as primary treatment for cavitary retinoblastoma: Excellent response in 8 tumors. Ophthalmology. Retina. 2020 Aug 24
doi: 10.1016/j.oret.2020.08.011.
https://pubmed.ncbi.nlm.nih.gov/32853834/

Zheng Y., Froehler M.T., Friedman D.L., Daniels A.B. Intra-arterial Chemotherapy as Primary Treatment for Cavitary Retinoblastoma: Excellent Response in Eight Tumors. Ophthalmology Retina. 2021 May;5(5):479-485.
doi: 10.1016/j.oret.2020.08.011
https://pubmed.ncbi.nlm.nih.gov/32853834/

Zheng Q., Zhu Q., Li C., Hao S., Li J., Yu X., Qi D., Pan Y. microRNA-144 functions as a diagnostic and prognostic marker for retinoblastoma. Clinics. 2020 Aug 19.
doi: 10.6061/clinics/2020/e1804.
https://pubmed.ncbi.nlm.nih.gov/32844953/

Zhou L., Zhu X.H., Zhang K., Hu R., Myers F. Case Report: Adult Retinoblastoma Progression in 19 Months. Optometry and vision science: official publication of the American Academy of Optometry. 2020 Oct 26.
doi: 10.1097/OPX.0000000000001602
https://pubmed.ncbi.nlm.nih.gov/33110028/

Zhou L., Zhu X.H., Zhang K., Hu R., Myers F. Case Report: Adult Retinoblastoma Progression in 19 Months. Optometry and vision science : official publication of the American Academy of Optometry. 2020 Nov;97(11):1010-1016.
doi: 10.1097/OPX.0000000000001602.
https://pubmed.ncbi.nlm.nih.gov/33110028/

Zhou M., Wen X., Jia S., Han Y., He X., Han M., Xu W., Fan J., Jia R., Fan X. Risk factors for ophthalmic artery stenosis and occlusion in patients with retinoblastoma treated with intra-arterial chemotherapy. The British journal of ophthalmology. 26 May. 2021
doi:10.1136/bjophthalmol-2021-319118
https://pubmed.ncbi.nlm.nih.gov/34039564/

Zhou Y., Cai S., Jin M., Jiang C., Xu N., Duan C., Peng X., Zhao J., Ma X. Economic burden for retinoblastoma patients in China. Journal of medical economics. 2020 Oct 27:1-5.
doi: 10.1080/13696998.2020.1831518.
https://pubmed.ncbi.nlm.nih.gov/33000977/

Zhou Z., Jiang H., Xia J., Zhang J. Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo. International journal of oncology. 2020 Jun 22.
doi: 10.3892/ijo.2020.5085
https://pubmed.ncbi.nlm.nih.gov/32582992/

Zhu X.Y., Li J., Guan W.B., Chen C.L., Ji X.D., Zhao P.Q. Pathologic comparisons of enucleated eyes with retinoblastoma after superselective ophthalmic arterial chemotherapy with or without intravenous chemotherapy. International journal of ophthalmology. 2020 Nov 18;13(11):1794-1799.
doi: 10.18240/ijo.2020.11.17.
https://pubmed.ncbi.nlm.nih.gov/33215012/

Zhu X., Yu M., Wang K., Zou W., Zhu L. FoxM1 affects adhesive, migratory, and invasive abilities of human retinoblastoma Y-79 cells by targeting matrix metalloproteinase 2. // Acta Biochimica et Biophysica Sinica. 2020 Mar 10.
DOI: 10.1093/abbs/gmz160
https://www.ncbi.nlm.nih.gov/pubmed/32152631

Zhu Y., Hao F. Knockdown of long non‑coding RNA HCP5 suppresses the malignant behavior of retinoblastoma by sponging miR‑3619‑5p to target HDAC9. International journal of molecular medicine. 2021 May;47(5):74.
doi: 10.3892/ijmm.2021.4907.
https://pubmed.ncbi.nlm.nih.gov/33693951/

Zluhan-Martínez E., Pérez-Koldenkova V., Ponce-Castañeda M.V., Sánchez M.P., García-Ponce B., Miguel-Hernández S., Álvarez-Buylla E.R., Garay-Arroyo A. Beyond What Your Retina Can See: Similarities of Retinoblastoma Function between Plants and Animals, from Developmental Processes to Epigenetic Regulation. International journal of molecular sciences. 2020 Jul 12
doi: 10.3390/ijms21144925.
https://pubmed.ncbi.nlm.nih.gov/32664691/

Zocchi L., Wu S.C., Benavente C.A. Heavenly HELLS? A potential new therapeutic target for retinoblastoma. Oncoscience. 2020 May 1.
DOI: 10.18632/oncoscience.502
https://pubmed.ncbi.nlm.nih.gov/32426419/?from_term=retinoblastoma&from_sort=date&from_page=2&from_pos=10

Zou Y., Li J., Hua P., Liang T., Ji X., Zhao P. Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing.
Molecular vision. 2021 Jan 6;27:1-16.
https://pubmed.ncbi.nlm.nih.gov/33456302/

Zugbi S., Ganiewich D., Bhattacharyya A., Aschero R., Ottaviani D., Sampor C., Cafferata E.G. etc. Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma. Cancers. 2020 Sep 22
doi: 10.3390/cancers12092714.
https://pubmed.ncbi.nlm.nih.gov/32971811/
Made on
Tilda